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ABSTRACT

Arylalkylamine N-acyltransferases (AANATs) have, in recent years, been
suggested as potential new insecticide targets. These promiscuous enzymes are involved
in the N-acylation of biogenic amines to form N-acylamides. Mammalian AANAT is
predominantly associated with circadian rhythm regulation, as it catalyzes the formation
of N-acetylserotonin, the precursor of melatonin, from serotonin. In insects, this process
is a key step in melanism, as well as hardening of the cuticle, removal of biogenic amines,
and in the biosynthesis of fatty acid amides. The unique nature of each insect AANAT
(iAANAT) isoform characterized indicates that while catalyzing similar reactions, each
insect genome contains distinct iAANATs relatively exclusive to that organism. This
implies a high potential for selectivity in insecticide design, while also maintaining
polypharmacology, and would make iAANATs a valuable target to combat insecticide
resistance. As highlighted by the World Health Organization, however, to develop an
effective resistance management plan (RMP), intrinsic biological knowledge of existing
and potential targets is vital to understand the development of resistance.
This dissertation is dedicated to the consolidation and expansion of our knowledge
of iAANATs both mechanistically and structurally. Significant efforts have thus far been
put in to characterizing this group of enzymes and their products in several different
insects. These efforts are highlighted and are built upon with the identification and
characterization of three novel iAANATs: TcAANAT1b and TcAANAT0 from Tribolium
ix

castaneum, and Bm-iAANAT3 from Bombyx mori. TcAANAT1b is a truncated form of the
putative dopamine N-acetyltransferase of T. castaneum: TcAANAT1. This shortened
‘splicoform’ was shown to be a significantly more active form of the enzyme, indicating a
catalytic importance of the N-terminus of iAANATs. TcAANAT0 was shown to be a much
more promiscuous enzyme, catalyzing the formation of short chain N-acylarylalkylamines
via ordered sequential mechanism, with short-chain acyl-CoAs (C2-C10) functioning in
the role of acyl-donor. The first crystal structure was also obtained for TcAANAT0 bound
to acetyl-CoA, revealing valuable information about its active site. Bm-iAANAT3 was
found to be a “versatile generalist”, functioning via a random kinetic mechanism. pH-rate
profiles generated for both enzymes indicated key catalytic residues which were used to
solve the chemical mechanism of both TcAANAT0 and Bm-iAANAT3. Both these
enzymes were also found to catalyze the formation of succinylated and malonated amides
respectively, indicating a potential panel of biologically occurring N-dicarboxylated
amines awaiting discovery. However, none of the above enzymes were found to catalyze
the formation of long-chain fatty acid amides, however. The previous characterization of
two enzymes, Bm-iAANAT and DmAANATL2, which do perform this role in vitro indicates
that some evolutionary divergence took place to separate short and long-chain acylators.
This

divergence,

which

led

to

the

specialization

of

the

arylalkylamine

N-

acetyltransferases, was found to likely be a result of organization of the amine binding
pocket, resulting in an active site less accommodating to long-chain acyl-CoAs.
The combination of kinetic analysis and crystallography, alongside phylogenetic
analysis, shines light on the heterogeneity of insect AANATs and garners further

x

discussion into their core differences, and some approaches possible to utilize these
enzymes in insecticide design.

xi

CHAPTER ONE:
INTRODUCTION AND MOTIVATION

Note to Reader: Portions of this chapter have been previously published in Biochemistry
& Molecular Biology Journal, 2018, 4, 1, 107-116 and has been reproduced as permitted
by Insight Medical Publishing (See Appendix A).
1.1

Enzyme heterogeneity
The epigraph for this work is from Coco Chanel, the celebrated French fashion

designer. Likely, her words “in order to be irreplaceable one must always be different”
were in reference to her significant influence in the fashion industry, especially concerning
the liberation of women from the suffocating clothing standards of the early 20th century.1
However, the quote rings true for many aspects of life, including in nature, as it effectively
captures the essence of enzyme evolution and of enzyme heterogeneity. To be of enough
use to a cell, i.e. to be worth the cost of transcription and translation, an enzyme must
provide some contribution to the overall fitness of the organism.2 Any divergence away
from the genetic formula of an enzyme will either be (and most often is) forgotten as a
failed mutation, or accepted, potentially heralding the way to a more robust, more
catalytically effective, or more promiscuous version of the original enzyme.3,4 This central
dogma of evolution has meant that today, enzymes, having gone through millions of years
of evolutionary stress and permutations, are highly ordered machines (Figure 1.1).

1

Everything about them has been tailored, from expression levels to location in the body,
to suit the organisms harboring them.5

Figure 1.1: The hypothesized process of enzyme evolution. Divergence from a common
ancestor leads to development of promiscuity and/or specialization, however the core
structure maintains resemblance to ancestors and other family members

Enzyme heterogeneity from organism to organism is a fascinating and vital topic
of research that has allowed us to understand our own evolutionary pathway, as well as
that of other organisms. It has also allowed us to control the natural environment around
2

us to unprecedented levels through proteome manipulation. One key facet of this is in the
advancement of genetic modification.6,7 For example, plants have evolved to utilize a cell
wall for protection and structure.8 The polysaccharide involved in the rigidity of the cell
wall, pectin, is broken down by the enzyme polygalacturonase.9–11 With some
exceptions,12,13 animals have mostly evolved beyond the need for polygalacturonase,14
likely due to our incorporation of gut microbes which perform its role.15 In 1992, Calgene
developed a form of tomato that was lacking in polygalacturonase. By removing the fruit’s
own ability to break down pectin, a strain of tomato was produced, named the Flavr Savr
tomato, which was made more resistant to rotting by slowing down pectin degradation.16
1.2

A brief history of pesticides
It is also by exploiting enzyme heterogeneity that we can chemically protect our

crops, stored produce and livestock, and reduce insect-transmitted diseases. The basis
of pesticide application is our ability to introduce a chemical, or group of chemicals, to the
organisms we are protecting. This chemical has been specifically designed to interfere
with pests, often through neurotoxicity, but minimize harm to non-targeted species, even
if the target enzyme or pathway is present in a wide berth of organisms. The first recorded
use of pesticides was by the Sumerians about 4,500 years ago, who applied sulfur
compounds against insects.17 Many of the first noted uses of pesticides were natural
products, such as pyrethrum, derived from the Chrysanthemum flower,18 and are still
found in circulation today. However, by the 1940’s, and the expansion of the increasingly
influential FDA, their relatively low selectivity and high levels of necessary application
meant that alternatives needed to be developed. A new collection of inexpensive, potent
synthetic pesticides was introduced to the market, led by dichlorodiphenyltrichloroethane
3

(DDT), a disruptor of insect sodium ion channels.19 The low toxicity DDT showed against
mammals, and targeted use to reduce insect-borne diseases, led its pioneer, Dr. Paul
Muller, to the Nobel Prize in Physiology or Medicine in 1949.20 This introduced a period
of contentment and, lamentably, an essence of naiveté, whereby with the apparent
success of this new class of pesticides, the long-term effects of such chemicals were not
in discussion. The release of Silent Spring in 1962 raised public awareness to the harms
of DDT.21 The chemical was found to bio-accumulate in fatty tissues, with continued
exposure leading to levels far higher than was considered ‘safe’. Among other concerns,
DDT was attributed to the decimation of the bald eagle population.22
The pesticide industry continued to grow in earnest, with many more synthetic
pesticides becoming commonplace. These designer pesticides, such as neonicotinoids,
introduced the industry to the next generation of pest control, with no bioaccumulation.23,24 Neonics, as neonicotinoids are often abbreviated, function as inhibitors
of nicotinic acetylcholine receptors and are currently the most widely used insecticide.25
However, recent honeybee health problems, especially colony collapse disorder, have
been attributed to the use (or claimed over-use) of many of these chemicals.26–30 Neonics
became the focus of a disproportionate amount of research emphasizing the dangers of
overuse. The rapid influx of research on the long-term effects of neonics was much
welcomed,31 especially considering the mistakes made previously with DDT. The use of
chronic sub-lethal toxicity to define the harm of neonics, however, does not give full
credence to the relative toxicity and efficacy when compared to other insecticides.32,33
While a comprehensive assessment by Dively, et al. demonstrated that long-term
exposure to neonics could have some marginal effects on queen numbers and
4

overwintering colony survival,34 many argue that neonics were merely on the wrong end
of a witch hunt. Indeed, the neonicotinoid controversy arguably took attention away from
other serious concerns. Due to the fact many pesticides on the market operate via a single
mode of action to increase selectivity,35 the issue of pesticide resistance is one of the
largest challenges faced by the industry going forward.
1.3

Insecticide resistance
It is apparent that through our attempts to control the environment, we are

inadvertently acting as a driving force for evolution and change.36–38 Specifically, by
introducing chemicals that target a particular metabolic pathway in an organism, we are
putting that organism under enormous unnatural evolutionary strain to survive in its
environment. Continued application of such an insecticide, for example, over several
generations of the target insect means that those insects born with a resistant allele will
be favored and carry on their resistance to proceeding generations (Figure 1.2).39–41 Since
some level of resistance has been seen for almost every major insecticide,42 they are of
primary concern, and are of most relevance to this body of text. Newly developed
insecticides are quickly becoming classified as “non-renewable resources”, with a
measure of effectiveness based on how long they will be commercially viable as a primary
concern.

5

Figure 1.2: Proposed mechanism of pesticide resistance. As the organism is exposed
to the pesticide, survivors carrying a resistant allele will be favored to pass on this
resistance to future generations. (From Campbell Biology: Concepts & Connections, 7th,
©2012. Reprinted by permission of Pearson Education, Inc., New York, New York.

Resistance management has become a key component in the development of new
insecticides, with the overall goal being to reduce the selection pressure for resistant
genes, while not sacrificing the effect of the insecticide. To accomplish this goal, the World
Health Organization and the Food and Agriculture Organization of the United Nations
released in 2010 the International Code of Conduct on the Distribution and Use of
Pesticides.42 The strategies outlined involve utilization of mixtures of insecticides with
different modes of action, rotation or alternation of insecticides, treatment number
restriction, and protection of beneficial organisms. The overarching tactic to combat

6

resistance, however, is through education; “it is important to learn as much as possible
about the biology of the pest.”
1.4

AANATs as a potential insecticide target
This dissertation concerns itself with the development of knowledge on one

particular class of enzymes which have been identified as potential insecticide targets;
the arylalkylamine N-acetyltransferases. Arylalkylamine N-acetyltransferases (AANAT),
often called dopamine- or serotonin N-acetyltransferases, are members of the Gcn5related N-acetyltransferase (GNAT) superfamily of enzymes. These enzymes catalyze
the acetyl-CoA-dependent acetylation of an amine or arylalkylamine (Figure 1.3).43

Figure 1.3: Mechanism for the AANAT-catalyzed N-acetylation of amines and
arylalkylamines
Since the initial characterization of Drosophila melanogaster AANAT by Maranda
et. al,44 a large number of insect genes encoding AANAT and AANAT-like proteins have
been described, highlighting the biological importance of these enzymes.45–52 In
vertebrates, AANAT catalyzes the rate-limiting step in the biosynthesis of melatonin and
has a key role in regulation of the sleep-wake cycle.53–55 AANATs found in insects
(iAANATs) are similarly involved in important biological processes, including insectspecific roles. It is a testament to the heterogeneity of this group of enzymes that each
7

insect family has developed family-unique AANATs to facilitate their own needs. iAANATs
are vital to cuticle morphology because they catalyze the acetylation of dopamine to Nacetyldopamine, a precursor to sclerotization, and hardening of the exoskeleton in many
insects.47,52,56 In addition to dopamine, a variety of biogenic amine neurotransmitters also
serve as acetyl group acceptors, meaning that the iAANATs are involved in
neurotransmitter inactivation and, thus, may contribute to the regulation of neural
signaling networks.57,58
An iAANAT-targeted insecticide would not only disrupt neural signaling, but would
also inhibit cuticle development, decrease the structural stability, resulting in a nonconforming appearance (harming the insects’ ability to mate), and diminish the cuticlemediated protection against injury and infection. The aforementioned AANAT-regulated
production of melatonin (by catalyzing the acetylation of serotonin) manages the life span
of Drosophila melanogaster, illustrating the toxicity potential of these biogenic amines if
their inactivation is interrupted. Insects are particularly susceptible to iAANAT inhibition
because insects lack the enzyme monoamine oxidase, an enzyme which functions in
mammals to inactivate such biogenic.58 It has long been an endeavour of ours to examine
the variety of functions of the iAANATs, and to ascertain the fatty acid amides they
produce. Thus far, we have successfully identified, cloned and characterized iAANATs
from Drosophila melanogaster and Bombyx mori.48–51,59–61

Other groups have

characterized iAANATs from other insects, including Aedes aegypti, Tribolium castaneum
and Antheraea pernyi.47,52,62,63 A picture of diversity and specificity for iAANATs emerges
from the kinetic analyses showing a broad range of amine and acyl-CoA thioester
substrates for the iAANATs, knockdowns demonstrating the detrimental effects of
8

targeting iAANATs, and sequence comparisons between the iAANATs revealing insectspecific targeting potential. All of these data point towards the iAANATs as excellent
targets for the design of novel insecticides.
As amine specificity varies between iAANATs, so too does acyl-CoA chain length,
ranging from acetyl-CoA to oleoyl-CoA. Based on the specificity of the acyl-CoA thioester
substrates, some iAANATs function in the formation of both short- and long-chain Nacylamides, whereas others function to catalyze the formation of predominantly shortchain or predominantly long-chain N-acylamides. For example, iAANATs found in D.
melanogaster show wildly differing results, especially with regards to acyl-chain length for
their respective acyl-CoA substrates. Acetyl-CoA is a substrate for D. melanogaster DmAANATA, KM = 39 ± 12 μM, but apparently had no appreciable affinity for the long-chain
acyl-CoA, arachidonoyl-CoA.48 Yet in the same organism, Dm-AANATL2 accepted both
acetyl-CoA and arachidonoyl-CoA as substrates, with KM values of 6.1 ± 0.3 μM and 1.9
± 0.25 μM, respectively, illustrating the differences in between the iAANATs found in the
same organism.50,59 This trend is similarly seen when comparing two iAANATs expressed
by B. mori.60,61 Acyl-chain length had negligible effect on the KM values for the acyl-CoA
substrates for Bm-iAANAT while Bm-iAANATL3 preferred acyl-CoA substrates with an
acyl chain length of 2-10 carbon atoms, with longer chain acyl-CoA thioesters not
acceptable as substrates, at all (Table 1.1).
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Table 1.1: KM values for the iAANATs found in D. melanogaster and B. mori with respect
to different acyl chain lengths

Acyl-CoA
Acetyl-CoA
Butyryl-CoA
Hexanoyl-CoA
Octanoyl-CoA
Decanoyl-CoA
Palmotyl-CoA
Oleoyl-CoA
Arachidonyl-CoA

(KM) (μM)
DmAANATA48
39 ± 12
36 ± 2
23 ± 3
18 ± 3
220 ± 60
N/A
N/A
N/A

DmAANATL250
6.1 ± 0.27
1.8 ± 0.17
N/A
N/A
N/A
9.9 ± 1.6
3.6 ± 0.58
1.9 ± 0.25

BmiAANATL361
90 ± 3.6
14 ± 0.75
13 ± 0.54
10 ± 1.0
12 ± 5.5
N/A
N/A
N/A

BmiAANAT60,64
0.31
N/A
N/A
N/A
N/A
1.1 ± 0.3
1.7 ± 0.51
1.2 ± 0.67

A review of the data for the amine substrates for the iAANATs again point to
specific metabolic functions for the specific members of the iAANAT family. Differences
of several orders of magnitude are found for amine KM values when comparing iAANATs
(Table 1.2). For example, the KM for dopamine with Dm-AANATA is 25 ± 2 μM and that
for Bm-iAANATL3 is 330 ± 23 μM. Differences like this are congruent for numerous
amines, signifying an evolutionary divergence in binding specificity in the active site
between iAANATs.
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Table 1.2: Binding constants for iAANATs found in D. melanogaster and B. mori with
respect to different amine acceptors

Amine
Tyramine
Octopamine
Dopamine
Tryptamine
Norepinephrine
Phenethylamine
Serotonin
4-methoxyphenethylamine
4-phenylbutylamine
3,4dimethoxyphenethylamine
Histamine
Putrescine
Agmatine
Spermine
N8-acetylspermine
Spermidine
Cadaverine

(KM) (μM)
DmAANATA48
12 ± 1
10 ± 2
25 ± 2
33 ± 3
32 ± 6
56 ± 13
110 ± 8
780 ± 60
270 ± 20

DmAANATL749
42 ± 2
120 ± 10
170 ± 20
26 ± 2
230 ± 50
320 ± 40
160 ± 20
190 ± 20
610 ± 30

3200 ± 300 320 ± 30
N/A
N/A
N/A
N/A
N/A
N/A
N/A

520 ± 50
81 ± 11
790 ± 100
N/A
N/A
N/A
N/A

DmAgmNAT51
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

BmiAANATL361
63 ± 6.7
18 ± 0.77
330 ± 23
97 ± 8.8
140 ± 8.6
N/A
1100 ± 63
N/A
N/A
N/A

N/A
51 ± 3
0.3 ± 0.02
18 ± 3
9.1 ± 1
17 ± 0.5
32 ± 6

1700 ± 98
N/A
N/A
N/A
N/A
N/A
N/A

Kinetic analyses provide a limited evaluation of the active site differences between
the iAANATs. The KM values are not Kdissociation values and a comparison (or ratio) of KM
values may only provide an estimate ratio of Kdissociation values for an acyl-CoA or amine
substrate. However, the highlighted differences in the KM values imply a large enough
distinction in substrate affinity to suggest that insecticides can be developed that will only
target iAANATs in insect pests. Another aspect in considering the iAANATs as insecticide
targets is to evaluate expression knockdown data. If the expression knockdown of a
potential insecticide target is not deleterious to the insect, then an inhibitor targeting it will
probably not be a useful insecticide. One such knockdown was performed by Long, et al.
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on Bombyx mori iAANAT2.64 The inhibition of Bm-iAANAT2 expression led to an increase
in melanin deposition in larvae and adults, resulting from increase cellular concentrations
of dopamine. As mentioned, any deviation in the appearance of the insect would have a
naturally detrimental effect on its chances of mating.65 Another iAANAT knockdown was
performed in T. castaneum, the red flour beetle, an insect regarded as a serious pest to
the food industry and hence a perfect model for insecticide target discovery.52 Noh et. al.
demonstrated that along with darkening of the cuticle, the knockdown resulted in a
separated, misshapen elytron (the wing casing of the beetle), and misfolding of the
hindwings of the beetle. The evidence demonstrates that targeting iAANAT compromised
the structural integrity of the T. castaneum exoskeleton. This naturally leaves the insect
vulnerable to a host of environmental threats, including disease, predation, and the
aforementioned inability to mate.
While the experimental data point toward the iAANATs as excellent targets for
insecticide development, insecticides, as mentioned, have come under scrutiny for their
toxicity against the honeybee, Apis melifera, and the bumblebee, Bombus terrestris. It is
here the iAANATs stand out as insecticide targets. An examination of the sequences for
numerous iAANATs reveals several unique iAANAT families. The “traditional” iAANAT
gene is easily identifiable through a CoA binding pocket motif (synonymous with the NAT
superfamily) and an insect specific motif, FxDEPLN. This motif contains functionally and
structurally important residues. Due to the link of the enzyme to dopamine acetylation,
this “traditional” iAANAT is often referred to as dopamine N-acetyltransferase (DAT).44
DAT is conserved among all insects. However, genome mining suggests that most
insects contain several other types of iAANATs, also with characteristic motifs. These
12

other families of iAANATs generally exhibit very low sequence homology outside of their
phylogenetic grouping. Generally speaking, there is less than 30% homology between
AANATs from insect to insect; and even between iAANAT families within the same
species, this number is usually around 40%. To add to this, A. melifera and B. terrestris
both contain an iAANAT specific for Apidae (bees). Coleoptera (beetles) contain several
more. This is further illustrated in Figure 1.4.

Figure 1.4: Primary sequence alignment of various insect AANATs, as well as human
serotonin N-acetyltransferase (SNAT). DAT specifies the conserved dopamine Nacetyltransferases found in all insects. iAANATs are the genus specific AANATs.
Highlighted in green is the amine binding pocket and highlighted in red are residues
that make up the CoA binding pocket. Both are noticeably generally conserved among
DATs but varied among genus-specific iAANATs. The nomenclature and associated
GenBank accession codes are as follows: AA – Aedes aegypti; DM – Drosophila
melanogaster; TC – Tribolium castaneum; BT – Bombus terrestris; AM – Apis mellifera;
HS – Homo sapiens. ‘AA DAT’ – XP_001661400.1; ‘DM DAT’ – NP_995934.1; ‘TC
DAT’ – XP_972873.2; ‘BT DAT’ – XP_012167469.1; ‘AM DAT’ – XP_016770090.1; ‘BT
iAANAT’ – XP_020723819.1; ‘AM iAANAT’ – XP_001122379.2; ‘AA iAANAT’ –
XP_001649422.1; ‘TC iAANAT’ – XP_973841.1; ‘HS SNAT’ - NP_001079.1

13

Importantly, the regions responsible for binding of both the acyl-CoA and the amine
substrate vary considerably between these iAANAT families, despite very high structural
homology. In all iAANATs, the overall secondary and tertiary structure of the amine
binding pocket is very similar. However, differences in specific residues are responsible
for changes in binding affinities. In Diptera- (fly) specific iAANATs, for example, many
hydrophobic residues are replaced with residues containing nucleophilic groups and
hydrogen bond acceptors that are not found in other iAANATs.57 This suggests that by
exploiting these catalytically relevant, yet insect-specific residues, it is possible to design
compounds that bind to a specific iAANAT family, such as Diptera iAANAT or Coleoptera
iAANAT, which would not bind (or would bind with low affinity) to others, leaving nontargeted species unaffected.
These comparisons of iAANATs reveal the potential for high insecticide specificity,
by solely targeting pests or disease vectors, and keeping agriculturally or ecologically
important species unharmed. Additionally, iAANATs share little to no sequential homology
to AANATs expressed in vertebrates. This is in stark contrast to the targets of many
currently used insecticides, such as the aforementioned neonicotinoids, as well as
organophosphates and organochlorines, which often have issues with non-specific
targeting,66 and often cause severe environmental side-effects.67 Further work must be
done to design and develop iAANAT-specific inhibitors to solidify these as legitimate
targets. However, the evidence discussed herein indicates the iAANATs are excellent
insecticide targets and the development of iAANAT-targeted inhibitors has the potential
to solve many of the problems faced by current insecticide development.
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The overarching goal of this dissertation is to develop our understanding of
iAANATs both structurally and kinetically. Chapter 2 outlines much of the preceding
research with regards the kinetic and chemical mechanism of iAANATs and their
biological role in insects. Chapter 3 is a case study on the heterogeneity of iAANATs, with
AANAT1 from T. castaneum as the subject. Chapter 4 presents a thorough
characterization of a novel AANAT from T. castaneum, named TcAANAT0. The kinetic
and structural information gained from this enzyme will be invaluable in the presentation
of iAANATs as a viable insecticide target. Chapter 5 details the mechanistic
characterization of Bm-iAANAT3 from Bombyx mori, one of the first AANATs reported
with a random sequential mechanism. Finally, Chapter 6 addresses a long-standing
question concerning AANATs; their role in long-chain fatty acid amide production. It is
hoped that the discussions presented herein establish the significance of iAANAT
heterogeneity and its place as a next generation insecticide target.
1.5
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CHAPTER TWO:
INSECT AANATS: MECHANISMS AND ROLE IN FATTY ACID AMIDE
BIOSYNTHESIS

Note to Reader: Portions of this chapter has been previously published in Frontiers in
Molecular Biosciences, 2018, 5, 66 and has been reproduced as permitted by Frontiers
(See Appendix A).
2.1

Introduction
The N-acylation of aromatic monoamines is mostly associated with the acetylation

of serotonin to form N-acetylserotonin, an N-acylarylalkylamide precursor in the formation
of melatonin.1,2 Production of N-acetylserotonin is the rate-determining step in the
biosynthesis of melatonin and the enzyme responsible is arylalkylamine Nacyltransferase (AANAT). The rhythmic production of melatonin, which regulates
circadian rhythms in mammals, correlates to rhythmic changes in AANAT activity.3,4 For
this reason, AANAT has been labeled the “timezyme”.5 Thus far, only one AANAT has
been characterized in mammals and most other vertebrates, with the exception being
bony fish, which contain an assortment of three AANAT isoforms.6,7 However, it has been
suggested that other AANAT-like enzymes are likely to exist in mammals because while
AANAT is primarily expressed with paracrine roles in the pineal gland and eyes, Nacylaryalkylamides are found in several regions of the body.2,8,9
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In contrast to vertebrates, non-vertebrates, including insects, express multiple
AANATs in order to regulate aromatic amino metabolism.10,11 For example, at least
thirteen and eight putative iAANATs have been identified in Aedes aegypti and Drosophila
melanogaster respectively.12–14 There are a number of plausible reasons why insects
express multiple iAANATs. Firstly, monoamine oxidase (MAO) activity is limited in
insects.15 In mammals, MAO is critical to the inactivation of catecholamines and other
aromatic amines.16 The inability to catabolize the catecholamines is linked to
schizophrenia, apnoea, psychosis, as well as physiological disorders related to prolactin
inhibition.17,18 To avoid a toxic buildup of these constituents, insects recruit numerous
iAANATs to inactivate catecholamines by N-acetylation.11,19 Secondly, the product of the
iAANAT-catalyzed acetylation of dopamine, N-acetyldopamine, is a key component in the
cuticle sclerotization process for many insects.20,21 Knockdown of AANAT associated with
dopamine N-acetylation in Bombyx mori, and Tribolium castaneum resulted in an
increase in intracellular concentrations of dopamine and other biogenic alkylamines and
the overproduction and deposition of melanin.22–24 The lack of acetylated dopamine gave
rise to abnormalities in the wing casings, misfolding of the hind wings, and a darkened
and malformed exoskeleton due to melanin overproduction. The cuticle is a vital barrier
from the environment, protecting the insect against injury and infection, while also
providing structural stability.25,26 Knockdown of Drosophila melanogaster AANATL2,
associated with the formation of long-chain N-acyldopamines and N-acylserotonins
resulted in decreased levels of N‐palmitoyldopamine, a proposed regulator of the
Hedgehog signaling pathway.27,28
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The low sequence homology (usually 20 – 40% identity) of these enzymes from
insect to insect implies that iAANATs could be a viable target for novel insecticide
design.29,30 Additionally, phylogenetic analysis demonstrates several apparent subgroups of iAANAT that could potentially offer specific targeting. These sub-groups are
best defined based on their substrate specificity. For example, a neighbor-joining tree
(Figure 2.1) of all characterized iAANATs divides these enzymes (with some exceptions)
into those which demonstrate standard dopamine-N-acetyltransferase activity, polyamine
N-acetyltransferase activity, and a more insect-specific N-acetyltransferase activity.31–34
The functions of these sub-groups are delegated among cuticle sclerotization,
neurotransmitter activation, and long-chain fatty acid amide formation, with some
iAANATs likely covering multiple roles.
It is apparent much remains to be unearthed about the iAANATs and their role in
catecholamine and aromatic amino acid metabolism. Much of this work comes from
examining the enzymes directly, for clues on how and why they function kinetically and
chemically. Presented in this chapter is an in-depth analysis of the structural and
functional relationships of the iAANATs and how the iAANATs contribute to the Nacylation reactions of aromatic amino acid metabolism in insects. A recent review has
been published on iAANATs, albeit with a different focus than that outlined here.11 It is
expected that this current chapter coupled to the review of Hiragaki and colleagues
provides a thorough analysis of the current state of knowledge of the iAANATs.
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Figure 2.1: Neighbor-joining tree built using Poisson-corrected distances on
characterized insect arylalkylamine N-acetyltransferases (iAANATs). The orange box
represents probable typical insect dopamine-N-acetyltransferases. The blue box
represents probable polyamine N-acetyltransferases. The red box represents putative
insect-specific N-acyltransferases. The percentage of replicate trees in which the
associated taxa clustered together in the bootstrap test (1000 replicates) are shown next
to the branches. The tree is drawn to scale, with branch lengths in the same units as
those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary
distances were computed using the Poisson correction method and are in the units of the
number of amino acid substitutions per site. Evolutionary analyses were conducted in
MEGA7.
2.2

N-Acetylation of the aromatic acids and aromatic amino acid – derived
metabolites
Early work identified the aromatic amino acids and other catecholamines in

insects.21,25,35,36 With the exception of tyrosine, insects are incapable of the de novo
synthesis of the aromatic amino acids and, thus, histidine, phenylalanine, and tryptophan
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are either obtained from the diet or via a symbiotic relationship with bacteria, fungi, and/or
plants.37–40
Histidine, phenylalanine, tyrosine, and tryptophan serve as the precursors to other
bioactive compounds in insects, including other aromatic amino acids that are not on the
canonical list of the 20 typically found in proteins: 3,4-dihydroxyphenylalanine (DOPA),
dopaquinone, kynurenine, and xanthommatin. The focus of this chapter is on the
enzymatic acylation of the α-amino group of the aromatic amino acids, which stems from
our interests in the biosynthesis of the fatty acid amides. Other chemical transformations
of specific aromatic amino acids in insects are discussed elsewhere: oxidation,41,42
decarboxylation,43,44

hydroxylation,45,46

transamination,47,48

phosphorylation,49,50

halogenation,51,52 and sulfation.53
Enzymes that catalyze the acyl-CoA-dependent acylation of the α-amino group of
aromatic amino acids are members of the Gcn5-related N-acetyltransferase (GNAT)
superfamily of enzymes.54,55 They have been described from insects under a variety of
names, including dopamine N-acetyltransferase, indolamine N-acetyltransferase,
indoleamine

N-acetyltransferase,

serotonin

N-acetyltransferase,

spermidine

N-

acetyltransferase, agmatine N-acetyltransferase, and arylalkylamine N-acetyltransferase
(AANAT).11 Much of the focus on these enzymes has been on amine N-acetylation, with
acetyl-CoA serving as the acetyl group donor. This is because of the importance of
dopamine acetylation in the sclerotization process,20 of serotonin acetylation in melatonin
biosynthesis,1 and of biogenic amine acetylation in their inactivation.42 It is also notable
that N-acetyltyrosine and N-acetylhistidine have been reported as metabolites in
insects.56,57
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Figure 2.2 The reaction catalyzed by arylalkylamine N-acyltransferase.
Fatty acid amides represent a large family of biologically occurring lipids of the
general structure, R-CO-NH-R1.58,59 This structural simplicity belies a wealth of diversity
amongst this lipid family as the R-group is derived from fatty acids (R-COOH) and the R1group is derived from the biogenic amines (H2N-R1). N-Fatty acyl derivatives of histidine,
phenylalanine, tyrosine, and tryptophan have been identified in insects.60,61 In addition,
N-fatty acyl derivatives of dopamine and serotonin have been identified in D.
melanogaster.62,63 We have proposed that novel iAANATs exist which will catalyze the
acyl-CoA-dependent formation of these N-fatty acylamides (Figure 2.2). AANATs in D.
melanogaster and B. mori have been identified that will utilize long-chain fatty acyl-CoA
thioesters as substrates leading to the production of these fatty acylamides.62,64 Thus, we
suggest replacing the name “N-acetyltransferase” with “N-acyltransferase” to better
reflect the most current data on this family of enzymes. Note that all the iAANATs
characterized to date will accept aromatic amino acid-derived metabolites as substrates
(dopamine, serotonin, tyramine, tryptamine, phenethylamine, and/or octopamine), but
none of the iAANATs that have been characterized will accept the aromatic amino acids
as substrates.14,30,62,65–70 In fact, we have reported that the aromatic amino acids and
tyrosine methyl ester do not bind to three D. melanogaster AANATs, DmAANATA,
DmAANATL2, and DmAANATL7, with any appreciable affinity (Kd > 10 mM) because
these compounds show no inhibition at 1.0 mM. 14,62,66
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The AANAT-catalyzed formation of N-acylamides is not the only reaction thought
to account for the synthesis of these molecules in insects. While thermodynamically
unfavorable under biological conditions, the biosynthesis of N-linolenoyl-L-glutamine in
Manduca sexta has been attributed to the direct conjugation of unactivated linolenic acid
to L-glutamine.71
N-β-Alanyldopamine (NBAD) and N-β-alanylhistamine (carcinine) are two other Nacylated aromatic amino acid-related compounds found in insects.72,73 These are
produced by an ATP-dependent reaction between β-alanine and dopamine or histamine,
catalyzed by the enzyme NBAD synthase (also known as Ebony). Mechanistic studies of
NBAD synthase show that β-alanine is initially activated by a reaction with ATP to yield
β-alanyl-AMP and pyrophosphate.74,75 The β-alanyl moiety is then transferred to the
sulfhydryl group of 4’-phosphopantetheine, a prosthetic group attached to Ser-611 in the
D. melanogaster enzyme. Nucleophilic attack by the amino group of dopamine or
histamine at β-alanyl-thioester yields NBAD or carcinine (Figure 2.3).
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Figure 2.3: The reaction catalyzed by NBAD synthase. The structures of two products
of the NBAD synthase reaction, NBAD and carcinine, are in the inset
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2.3

Insect AANAT – Kinetic mechanism
Due to the bi-substrate, bi-product (bi-bi) nature of the reaction, there are two

possibilities for the iAANAT kinetic mechanism: sequential or non-sequential (ping-pong).
A sequential kinetic mechanism is divided further into either ordered or random
mechanisms by determining if one of the substrates requires the formation of an enzymesubstrate (E•S) complex before binding.76 Protocols to differentiate between steady-state
ordered and rapid-equilibrium ordered bi-bi kinetic mechanisms involve initial velocity
kinetic experiments varying one substrate at different fixed concentrations of the second
substrate in the presence and absence of a dead-end inhibitor. The trends given by these
types of experiments are fingerprints for the elucidation of the kinetic mechanism.
Supplementary experiments such as measurements of direct substrate binding and/or
kinetic isotope effects are often illustrative. Both sequential and ping-pong mechanisms
have been attributed to iAANATs; however, the most common is a sequential mechanism.
Early studies of an iAANAT from the American cockroach, Periplaneta americana.
demonstrated that this enzyme functioned via a sequential kinetic mechanism.68,77
iAANATs from other insects were purified and characterized following the work on the P.
americana AANAT. iAANATs from Acyrthosiphon pisum (pea aphid),78 Aedes aegypti
(yellow fever mosquito),12,69 Antheraea pernyi (silkmoth),30 Bombyx mori (silkworm),22,70
Dianemobius nigrofasciatus, (band-legged cricket),79 Drosophila melanogaster (fruit
fly),13,80,81 and Tribolium castaneum (red flour beetle),24 were purified and characterized,
often including a set of biogenic amine substrates evaluated using acetyl-CoA as the acyl
donor. However, determination of the kinetic mechanism for these various iAANATs was
not included in these cited works.
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Our work in this field started with the hypothesis that iAANATs were responsible,
not just for short chain N-acylation, but also for long chain N-acylation to form Noleoylated, N-palmitoylated, and, perhaps, N-arachidonylated amines. Drosophila
melanogaster presented the ideal model organism; the flies were known to produce Nfatty acylamides and to express at least eight different iAANATs.13,61,63 Dempsey et al.
demonstrated that D. melanogaster AANATA (DmAANATA) followed an ordered
sequential mechanism, with acetyl-CoA binding first and catalysis only taking place after
the formation of the DmAANATA•acetyl-CoA•tyramine complex.14 We built on our work
on DmAANATA leading to expression and characterization of three other AANAT-like
enzymes from D. melanogaster, DmAANATL2,62 DmAANATL7,66 and DmAANATL8.65
The best substrates for DmAANATL8 were agmatine and acetyl-CoA, so we renamed
DmAANATL8 as DmAgmNAT – agmatine N-acetyltransferase. Our data for all three of
these D. melanogaster iAANATs were consistent with a steady-state ordered kinetic
mechanism with the acyl-CoA substrate binding first for all three of these DmAANATs.
We have recently broadened our scope beyond D. melanogaster to Bombyx mori,
another insect known to express multiple iAANATs. Three B. mori iAANATs have been
described and partially characterized: Bm-iAANAT,64,70 Bm-iAANAT2,22 and, described in
Chapter 5, Bm-iAANAT3.82 We found that the kinetic mechanism for Bm-iAANAT3 was
steady-state ordered with the acyl-CoA substrate binding first, similar to kinetic
mechanisms elucidated for iAANATs from D. melanogaster and P. americana. Structural
studies by Aboalroub et al. revealed that the binding of acetyl-CoA to Bm-iAANAT3 alters
the conformation of the enzyme to facilitate binding of the amine substrate.83 In the
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absence of acetyl-CoA, the amine substrate binds with relatively low affinity to BmiAANAT3.
2.4

Insect AANAT – Catalytic mechanism
The kinetic mechanism of an enzyme provides only a partial insight of the

intricacies of enzymatic catalysis. To get a more complete picture of the specific
interactions that mediate catalysis, work must be done to elucidate a chemical
mechanism. Delicate balances between pH, residue positions, and both local and longranged readjustments in active site orientation offer a fascinating conundrum which is
only now beginning to be understood thanks to a combination of experimental,
computational and quantum mechanical studies. To investigate the catalytic mechanism
is to understand the very intricate subtleties that regulate enzyme catalysis.
One goal of the mechanistic work on the iAANATs is to understand the pHdependence of catalysis regarding the protonation state of critical active site amino acids.
Asano and Takeda first noted the importance of pH to iAANAT activity in their work on
the P. americana iAANATs.77 They identified one acidic and one basic form of the P.
americana enzymes. The optimal pH for acidic iAANAT was approximately pH 6.0,
whereas that for the basic form was approximately pH 10. Definitive mechanistic
conclusions about the P. americana iAANATs could not be drawn because their data was
generated using only one concentration of both substrates rather than a more complete
pH-rate profile obtained by varying both substrates as pH was varied. To date, only one
other iAANAT, from D. nigrodasciatus has been described that has maximum activity at
pH < 7.0.79
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Activity profiles as a function of pH were reported for two iAANATs from A. aegypti,
AaNAT2 and AaNAT5b. Activity was maximum between pH 8 and 9 with either a
decrease in activity as pH was increased (AaNAT5b) or a relatively constant level of
activity as pH was increased (AaNAT2).12 Similar trends were noted in the pH vs. activity
data for other iAANATs in Antheraea pernyi and Tribolium castaneum, except that the
maximum activity was observed at a lower pH, pH 7.5 to 8.5.24,30
While these data are interesting and useful, these studies do not provide
conclusive mechanistic information about iAANAT-mediated catalysis. Instead, a more
complete analysis (varying both substrates) to measure the pH-dependence of the KM,
kcat, and kcat/KM values must be undertaken. Such studies were carried out on four
iAANATs from D. melanogaster, DmAANATA.14,80 DmAANAT2,62 DmAANATL7,66 and
DmAgmNAT.65
Some overlapping trends were observed in the pH-rate profile data on these four
D. melanogaster AANATs. Catalysis was dependent on a general base, which exhibited
a pKa of approximately pH 7.5. A similar trend was observed in pH rate profiles of BmiAANAT3, except the general base had a pKa of approximately 6.8 for this enzyme.82 One
other interesting nuance of the pH rate data on the D. melanogaster and B. mori AANATs
was a bell-shaped curve, indicating the presence of a second catalytically important
residue with a pKa of 9-10.14,67,80 One suggestion to account for the second pKa is an
active site Ser serving as a general acid to protonate the thiolate anion of coenzyme A
(CoA-S-) (Cheng et al., 2012).80 An active site Ser serving as a general acid is unusual in
enzymatic chemistry because this would require a significant decrease in pKa of the serine
hydroxyl from 13-14 to 9-10. More likely, this second pKa reflects the pKa of the departing
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CoA-SH, pKa = 9.6 to 10.4,84 meaning that that the release of CoA-S- is slower for the
iAANATs.
Alanine-scanning mutagenesis, sequence alignments, and crystallographic data
(when available) were all use to alleviate the ambiguity of some of the results and to
assign residue-specific roles in iAANAT catalysis. Sequence alignments demonstrated
several conserved motifs, representative of structurally or catalytically relevant residues
(Figure 2.4). Within the iAANATs, we noted a highly conserved DEPLN motif (Figure 2.5)
– an obvious target for mutagenesis. Mutation of the glutamate in this motif to alanine,
Glu-47 in DmAANATA,14 Glu-26 in DmAANATL7,66 Glu-34 in DmAgmNAT,65 and Glu-27
Bm-iAANAT3,82 resulted in an almost complete eradication of iAANAT activity. The pHrate profiles for Glu-to-Ala mutants in DmAANATA, DmAANATL7, and DmAgmNAT
strongly supported a role for the Glu in the DEPLN motif serving as the general base
during catalysis. For the mutant iAANATs, the acidic pKa disappeared and the resulting
pH-rate profiles were either flat (no dependence of the residual rate on pH) or exhibited
a linear relationship with pH (slopes from 0.2 to 0.7) suggesting a “rescue” of catalytic
activity by hydroxide as the pH increased. The mutagenesis data also show the Glu in
DEPLN motif must function in substrate binding since the respective Glu-to-Ala mutants.
We must point out that the Glu in the DEPLN also has a role in amine binding because
the KM,amine values increased significantly for the E47A mutant in DmAANATA, the E26A
mutant in DmAANATL7, and the E34A mutant in DmAgmNAT.
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Figure 2.4: Sequence alignment of iAANATs. Residues are colored depending on acidic
(red), basic (blue), polar (green), or hydrophobic (yellow). Cysteines are in gold and
glycine is purple. Aedes aegypti – AaNAT1 (GenBank accession no. XP_001661400);
AaNAT2 (GenBank accession no. XP_001663122); AaNAT5b (GenBank accession no.
XP_001649916); Bombyx mori – Bm-iAANAT (GenBank accession no.
NM_001079654.2); Bm-iAANATL3 (GenBank accession no. NM_001190842.1);
Drosophila melanogaster – DmAANATA (GenBank accession no. NM_079115.3);
DmAANATB (GenBank accession no. NM_206212.1); DmAANATL2 (GenBank
accession no. NM_135161.3); DmAANATL7 (GenBank accession no. NM_130653.3);
DmAgmNAT (GenBank accession no. NP_572268.1); Periplaneta americana – PaNAT
(GenBank accession no. BAC87874.1); TcAANAT1 – Tribolium castaneum (GenBank
accession no. NM_001145908.1)
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Figure 2.5: Crystal structure of DmAANATA (PDB: 3TE4) active site with bound acetylCoA. Residues shown in cyan represent DEPLN region conserved among many iAANATs

One exception to the pattern of results obtained for DmAANATA, DmAANAT7,
DmAgmNAT, and Bm-iAANAT3 was DmAANATL2.67 The E29A mutant for DmAANATL2
showed only a relatively slight decrease in the kcat relative to wildtype as well as a bellshaped pH-rate profile yielding the same pKa values as wildtype. Thus, for DmAANATL7
the general base required for catalysis with a pKa value of ~7.4 is not Glu-29 and is
currently unknown. As we found for the other D. melanogaster AANATs, the Glu in the
DEPLN motif for DmAANATL2 has a role in amine substrate binding because the KM,amine
increased ~20-fold relative to wildtype without any change in the KM,acetyl-CoA value.
Availability of a crystal structure for DmAANATA (PDB accession code: 3TE4)80
and DmAgmNAT (PDB accession code: 5K9N)65 allowed for more in-depth structural
analysis. Combined with this, homology models were developed using SWISS-MODEL
for DmAANATL2 (based on 3TE4 and 5GIF) and DmAANATL7 (based on 4FD6).12,85
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Both Glu-47 in DmAANATA and Glu-34 in DmAgmNAT are located in their respective
active sites with several structural waters positioned within proximity (Figure 2.6). This
led to the suggestion that these water molecules form a “proton wire” to assist the general
base in catalysis by facilitating proton transfer, as had been suggested in other GNAT
enzymes.54

Figure 2.6: Crystal structure of DmAANATA (PDB: 3TE4 - cyan) active site with bound
acetyl-CoA aligned with apo structure of DmAgmNAT (PDB: 5K9N - orange). Highlighted
residues indicate Glu-47 and Glu-34 which function respectively in these enzymes as the
apparent general base. The surrounding water molecules (colored spheres) enable a
“proton wire” to facilitate proton transfer.
Sequence alignment of the iAANATs also revealed a highly conserved arginine
residue, Arg-153, which based on the crystal structure of DmAANATA, seemed
necessary in maintaining structure. A salt bridge is formed between Arg-153 and Asp-46
(Figure 2.7).80 Surprisingly, the kcat for the R153A mutant in DmAANATA was ~5-fold
higher than wildtype. Corresponding increases in the KM for both substrates resulted in
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the kcat/KM for the R153A being 2-5 fold lower than wildtype.14 We attributed the results
for the R153A mutant to elimination of the R153-D46 salt bridge that is critical to a
DmAANATA conformation that decreases the rate of CoA-SH release. This argument
suggests that Arg-153 does not have a direct role in catalysis and, further, points towards
a partially rate-determining conformational change in DmAANATA, which has been
observed in other GNAT enzymes.54,55 Arg-138 in DmAANATL7 and Arg-138 in
DmAANATL2 are equivalent to Arg-153 in DmAANATA. Data generated for the R138A
mutant in DmAANATL7 was similar to what was found for the R153A mutant of
DmAANATA, again, arguing against a direct role of Arg-138 in DmAANATL7 catalysis

Figure 2.7: Crystal structure of DmAANATA (PDB: 3TE4 - cyan) active site with bound
acetyl- CoA aligned with homology models of DmAANAT2 (magenta) and DmAANATL7
(yellow). Illustrated by the yellow dashes is the salt bridge that forms between Asp-46
and Arg-153 of DmAANATA.
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and for a partially-rate determining conformation change regulating the release of CoASH.66
DmAANATL2 proved different.66 Mutation of Arg-138 to Ala in DmAANATL2
resulted in kcat values that are ~20% of the wild-type enzyme and KM values similar to the
wild-type. These data imply that Arg-138 may have a direct role in DmAANATL2 catalysis
and that a conformational change involving Arg-138 is not particularly rate-determining
for this iAANAT. Homology modeling of DmAANATL2 based on DmAANATA (PDB
access code: 3TE4) indicates a conserved position for the respective arginine residues.
The different effects mutation of this residue has on kcat for both enzymes implies that
Arg-138 of DmAANATL2 may share catalytic and conformational responsibilities. An
alternative residue perhaps fills the role for this catalytic residue in wild-type DmAANATA
and in DmAANATL7, or possibly in the mutated species as a “rescue” in the absence of
the arginine residue. HSQC-NMR titrations of both wild-type and mutated species could
be employed to examine this phenomenon. However, because of the apparent
aggregation of many of these enzymes at high concentrations, NMR is usually difficult
and often impossible to perform.
The structure of DmAANATA indicated that His-220 was in van der Waals contact
with Pro-48 of the active site (Figure 2.8A).80 Sequence and structural alignments of
iAANATs reveal this His to be relatively well conserved (Figure 2.8B). The H220A mutant
exhibited 4-7-fold increase in KM and a 4-fold decrease in kcat – a trend observed in the
corresponding His-to-Ala mutants in DmAANATL7 (His-206) and in DmAgmNAT (His206). The DmAgmNAT crystal structure demonstrated clearly that His-206 was important
to the formation of the active site through interaction with numerous residues in its
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environment (Figure 2.8C). DmAANATL2 was again an outlier in this aspect, with
mutation of its respective histidine, His-206, resulting in a mutant enzyme completely
devoid of catalytic activity.66 The creation of an inactive H206A mutant of DmAANATL2
is difficult to interpret. His-206 may be essential to structural integrity of the enzyme or
may have an essential role in catalysis.

Figure 2.8: The importance of the active site histidine of iAANATs in the structural
maintenance of the active site. (A) Crystal structure of DmAANATA (PDB: 3TE4 - cyan)
active site with bound acetyl CoA. Spheres indicate relative proximity of His-220 and Pro48, which in turn facilitates van der Waals contact. (B) Alignment of DmAANATA (PDB:
3TE4 - cyan), DmAgmNAT (PDB: 5K9N - orange), DmAANAT2 (magenta) and
DmAANATL7 (yellow) demonstrating conservation of this active-site histidine. (C) Crystal
structure of DmAgmNAT (PDB: 5K9N - orange) highlighting numerous interactions of His206 with surrounding residues, confirming its importance in active-site formation.
While one set mechanism has not been agreed upon for iAANAT catalysis, there
are at least two plausible suggestions that agree with the available data. The first
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represents an ordered sequential mechanism, where the acyl-CoA binds first, followed by
the amine substrate. This leads to the formation of an iAANAT•acyl-CoA•amine ternary
complex before catalysis can occur. From here, a catalytic base (generally a glutamate,
but possibly a histidine in DmAANATL2) deprotonates the positively charged amine
moiety through the use of a “proton wire” of ordered water molecules. Nucleophilic attack
of the carbonyl of the acyl-CoA thioester generates a zwitterionic tetrahedral intermediate.
This collapses as the CoA-S- is protonated by the positively charged amine of the
intermediate, thus, relinquishing the two products, most likely in the order of N-acylamide
first, followed by CoA-SH (Figure 2.9). This mechanism is equivalent to that proposed for
serotonin N-acetyltransferase found in mammals.86
The second mechanism proposed represents the involvement of a general acid.
Following binding of the substrates to form the iAANAT•acyl-CoA•amine ternary complex,
nucleophilic attack of the carbonyl of the acyl-CoA thioester by the amine generates a
zwitterionic tetrahedral intermediate. Collapse of this is catalyzed by a general base
deprotonation of the positively charged amine intermediate, as well as a general acid
protonation of CoA-S-, yielding the two products. While this mechanism cannot be
eliminated by the available mechanistic data on the iAANATs, this mechanism is less
favored, due to questions about an active site amino acid serving as a general acid during
catalysis.
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A

B

Figure 2.9: Proposed catalytic mechanisms for iAANAT. (A) Mechanism demonstrating
a general base functioning to deprotonate the positively charged amine yielding a
zwitterionic tetrahedral intermediate. Subsequent protonation and release of the
CoA-SH product yields the final fatty acylamide product (B) Mechanism demonstrating
both a general base and general acid functioning in intermediate collapse and release
of the CoA-SH and fatty acylamide products
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2.5

Insect AANAT – a “timezyme”?
As mentioned, in vertebrates, AANAT is involved in regulating circadian rhythms.

It cannot be assumed, however, that the AANATs function in the same way in insects.
Circadian rhythms are any biological process that follow a daily cycle; sleeping at night
and being awake in the day is a common example of a light-related circadian rhythm. The
driving force behind the circadian rhythm of any organism is the innate biological clock.
The rhythmic pattern of this clock is maintained through a complex, feedback induced,
pathway associated with clock genes and their related proteins.87 Entrainment of this
pathway is controlled by mediation of melatonin levels,88 which is dependent on
photoperiodic messages, i.e. light exposure to the eyes. The changes in melatonin levels
lead sequentially to photoperiodic responses. Vertebrate AANAT is expressed in
photosensitive organs such as the pineal gland, retina, and parietal eyes demonstrating
a clear association with photoperiodic signaling in vertebrates;11,89 thus, AANAT was
termed the ‘timezyme’.5 In insects, it is unknown how photoperiodic signaling is integrated
into daily rhythms because insect eyes are usually insufficiently photosensitive.3,90 This
suggests insects may rely on other environmental cues rather than light alone to
distinguish between night and day. A few insects, however, have shown the ability to
interpret photoperiodic stimuli, namely P. americana, L. migratoria, D. nigrofasciatus, and
L. hedyloidea.79,91–93
The classification of an iAANAT as a ‘timezyme’ is unclear because the exact role
played by melatonin in insect physiology is not fully understood and what constitutes a
daily rhythm in insects is not fully defined. In some insects, melatonin and AANAT content
fluctuate in a circadian manner, one case being P. americana.68,91 Because of their
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complex eye structure,94 P. americana are capable of interpreting a photoperiod message
as a temporal cue in order to initiate physiological responses that allows them to
distinguish between night and day.89 In contrast to P. americana, melatonin and AANAT
production failed to follow any circadian patterning in D. melanogaster.13
While the link between circadian rhythms and the photoperiodic system remains
largely unknown in insects, previous studies have hinted at a possible link between
circadian

clock

systems

and

diapause.88,95

Three

families

of

hormones,

prothoracicotropic hormone (PTTH), ecdysteroids, and juvenile hormones (JHs) are vital
in regulating diapause and pupation. These hormones work in daily rhythms during insect
larval stages, and therefore can be categorized as circadian rhythm regulators.96,97 In A.
pernyi, melatonin regulates PTTH release, acting as an endocrine switch, thereby,
connecting circadian rhythms with endocrine function.98 Mohamed et al. demonstrated
that iAANAT is the critical switch regulating PTTH and, subsequently, diapause. By acting
as a regulator of this endocrine system, iAANAT may enable a wide variety of insects to
maintain homeostasis and circadian function.
It has been seen in few insects that both melatonin synthesis and iAANAT
expression follow a circadian rhythm. There are other insects, such as A. pernyi, where
iAANAT acts as a mediator of circadian rhythms and endocrine systems through the
regulation of PTTH. In this case, of A. pernyi having the ability to interpret photoperiodic
responses, melatonin secretion is known to participate in PTTH stimulation. From the
evidence presented, we cannot argue definitively that iAANATs are insect “timezymes”.
It is just not clear if iAANATs are directly involved in regulating circadian rhythms like what
has been demonstrated in vertebrates. However, iAANATs do seem to mediate rhythmic
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processes within insects, meaning that iAANATs, and, perhaps; AANATs in general, are
more appropriately referred to as ‘rhymezymes’.
2.6

Conclusion
Outlined in this chapter is what is currently known about N-acylated derivatives of

the aromatic amino acids and the N-acylated derivatives of the biogenic amines produced
in vivo from the aromatic amino acids: dopamine, serotonin, tyramine, tryptamine,
phenethylamine, and octopamine. Most, if not all, of these metabolites found in insects
are produced enzymatically in a reaction catalyzed by an insect arylalkylamine Nacyltransferase. iAANATs from a number of different insects have been purified and
characterized. Detailed studies have established that the kinetic mechanism for many
iAANATs is steady-state ordered with the acyl-CoA substrate binding first and catalysis
taking place only after the formation of the iAANAT•acyl-CoA•amine complex. An activesite Glu residue found in a highly conserved DEPLN motif is often the general-base critical
to iAANAT catalysis. In addition, alanine-scanning mutagenesis of D. melanogaster
iAANATs points toward a rate-determining conformational change that may regulate
product release. An expanding base of structural information for the iAANATs will only
deepen our understanding of iAANAT-mediated catalysis.
The research summarized herein points out some future research directions: the
identification of other N-acylated metabolites in insects, defining the function, receptors,
and transporters for these molecules in insects, identifying the enzyme responsible for
the biosynthesis and degradation of the N-acylated biogenic amines, and the use of
mechanistic, sequential and structural information about the iAANATs for the
development of iAANAT-specific insecticides to control insect pests. The low sequence –
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high structural homology has always been a characteristic of insect AANATs. Also
apparent is how key conserved residues, such as Arg-153 in DmAANATA and Arg-138
in DmAANATL2, can have different functions in catalysis or structure. This example
illustrates that much remains to be learned about the intricate interplay between structure
and catalysis for iAANATs. Conformational dynamics are important to substrate binding
and catalysis for the GNAT family of enzymes,54,99–101 including the iAANATs.14,102
Solution NMR is an excellent method to study protein dynamics, yet has found little
application towards GNAT enzymes.103,104 The iAANATs provide examples for NMR
investigations of protein dynamics because these proteins are often monomeric, small
(molecular weights <35 kDa), do not aggregate at mM concentrations, and are expressed
at high levels in E. coli. Thus, solution NMR investigations of the iAANATs could yield
important new insights into the role of dynamics in the structure/function relationships for
the GNAT enzymes.
The role served by the iAANATs in vivo is a source of debate. Due, in part, to the
link between mammalian AANATs and the circadian rhythms, it is easy to assume
iAANATs play a similar role in insects. It is apparent this is not the case, with each insect,
and their corresponding group of iAANATs present a unique model for metabolomics
investigations.
2.7
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CHAPTER THREE:
IDENTIFICATION OF CATALYTICALLY DISTINCT AANAT SPLICOFORMS FROM
TRIBOLIUM CASTANEUM

3.1

Introduction
The Gcn5-related N-acetyltransferase (GNAT) superfamily of enzymes are known

to catalyze the acyl-CoA-dependent acylation of an amine or arylalkylamine;1,2 examples
include

the

arylalkylamine

N-acyltransferases

(AANATs),3,4

N-acetylglutamate

synthetase,5 and the histone acetyltransferases.6 Genomic screens have shown that
multiple GNAT-like enzymes could be expressed in an organism.7–9 One possible reason
for the heterogeneity of GNAT enzymes in an organism lies in the array of functions
mediated by these enzymes.6,10–16 In mammals for example, only one AANAT has been
identified, serotonin N-acetyltransferase (SNAT),11 an important regulator of mammalian
circadian rhythm. On the other hand, insects express an abundance of AANAT and
AANAT-like enzymes. This is consistent with the understanding that insect AANATs
perform a variety of roles, including cuticle sclerotization, biogenic amine removal, and
fatty-acid amide biosynthesis.14–18 Much effort has been put into identifying and
characterizing these enzymes and the panel of substrates each incorporates, from both
an acyl-CoA donor and amine acceptor perspective.7,17,19–33
It has been shown that iAANATs generally show <40% sequence homology but
demonstrate remarkable structural conservation;34 four conserved sequence motifs and
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a common fold core are synonymous with all GNAT enzymes, despite the low pairwise
sequence identity.1 Additionally, many iAANATs characterized to date have demonstrated
significant variation in activity, especially regarding specificity for the amine acceptor.
While this can be expected between enzymes that share little similarity, it is important to
note that even variants of the same gene, expressed through alternative splicing, can
serve different metabolic purposes. This has previously been demonstrated for
DmAANATA and DmAANATB, wherein a truncation of 35 amino acids from the Nterminus results in two distinct proteins with differing tissue distribution and instar
expression levels.28 Minimal variation in substrate specificity across a panel of biogenic
amines tested, however, provided no clear insight into the distinction of these
splicoforms.19 As was noted, it is possible that the differences could be due to some
unrevealed substrate specificity, or indeed separate modes of regulation between the two
enzymes.
Recently, an AANAT from another insect, Tribolium castaneum, was shown to be
a key component in cuticle sclerotization and pigmentation.24 The enzyme, TcAANAT1,
catalyzes the formation of acetylated amines with dopamine, tryptamine, norepinephrine,
tyramine and octopamine functioning as the acceptor substrate. A BLAST search of the
T. castaneum genome using TcAANAT1 as a template identified two separate AANATs,
the aforementioned TcAANAT1 and TcAANAT0, the characterization of which is outlined
in Chapter 4. Also identified were several isoforms of TcAANAT1. One such isoform is a
truncated version of the enzyme, 24 amino acids shorter: TcAANAT1b. We set about
examining the effect of truncation on catalytic efficiency and substrate specificity. To do
this, we utilized a convenient and straightforward strategy to identify substrates for GNAT
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enzymes and any other enzymes that utilize acyl-CoA thioesters as acyl donors. This
screening strategy allowed us to show that truncation of TcAANAT1 does indeed result
in a catalytically distinct version of the enzyme with significantly higher levels of activity.
Through sequence and structural analysis, we then examined the reasoning behind this
contrast.
3.2

Results and discussion

3.2.1 Amine screening
A screening strategy, outlined in section 3.4.2, was utilized to determine substrate
specificity. A truncated selection of three amine pools tested with acetyl-CoA, all with very
different activities, is presented in Table 3.1. Pool 1 and 2 demonstrated activity above
the control threshold as defined by Equation 3.1 (Discussed in section 3.4.1). Each amine
was then individually examined to determine which acted as substrate for the enzyme.
Table 3.1: Screening results for three distinct pools of amines. All units are in A/min
Pool

1

2

3

Pool contents
Lysine
Threonine
Glycine
Histamine
Serotonin
Dopamine
Tryptamine
Norepinephrine
Aspartate
Isoleucine
Tryptophan
Glutamine

x̅s

σs

x̅c

σc

Z-Factor

Pass or fail?

5.4

0.27

0.014

0.001

0.85

Pass

0.57

0.08

0.014

0.001

0.56

Pass

0.043

0.004

0.014

0.001

0.42

Fail
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3.2.2 Amine steady-state kinetic constants
In total, eight amines were found to have activity with TcAANAT1b with acetyl-CoA
acting as donor: dopamine, octopamine, serotonin, 2-phenethylamine, norepinephrine,
2,2-difluoro-2-phenethylamine, histamine, tryptamine and tyramine. This panel points to
TcAANAT1b having a function in biogenic amine neurotransmitter inactivation. Their
respective kinetic constants are presented in Table 3.2 While tryptamine and tyramine
were substrates, a strong tendency to inhibit at low concentrations made it difficult to
accurately measure rates.
Table 3.2: Steady-state kinetic constants of most active amine substrates for
TcAANAT1b. Kinetic constants were measured using 300 mM Tris-HCl, pH 8.0, 375 µM
DTDP, and 250 µM acetyl-CoA
Substrate
Dopamine
Octopamine
Serotonin
2-Phenethylamine
Norepinephrine
2,2-Difluoro-2-phenethylamine
Histamine

KM (μM)
9.7 ± 2.0
18 ± 5.9
42 ± 10
81 ± 22
53 ± 9.9
327 ± 43
1,400 ± 190

kcat (s-1)
26 ± 1.2
40 ± 5.1
70 ± 11
87 ± 14
41 ± 2.5
85 ± 3.8
59 ± 2.8

kcat/KM (M-1s-1)
(2.7 ± 0.5) x 106
(2.2 ± 0.7) x 106
(1.7 ± 0.1) x 106
(1.1 ± 1.1) x 106
(7.7 ± 1.5) x 105
(2.6 ± 0.4) x 105
(4.3 ± 0.6) x 104

Despite other substrates showing a faster turnover rate, the low KM for dopamine
means it is likely the endogenous ligand for TcAANAT1b. This is in good agreement with
the findings for TcAANAT1, due to its association with cuticle morphology and
pigmentation. While both enzymes share five common substrates; dopamine,
octopamine, tryptamine, tyramine and norepinephrine, the respective kinetic constants
are very different for these enzymes, as shown in Table 3.3.
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Table 3.3: Kinetic constants recorded for different variants of TcAANAT1
TcAANAT1
Dopamine
Octopamine
Norepinephrine
TcAANAT1b
Dopamine
Octopamine
Norepinephrine

KM (μM)
110 ± 40
70 ± 10
50 ± 30
KM (μM)
9.7 ± 2.0
18 ± 5.9
53 ± 9.9

kcat (s-1)
0.5 ± 0.1
0.4 ± 0.06
0.1 ± 0.03
kcat (s-1)
26 ± 1.2
40 ± 5.1
41 ± 2.5

kcat/KM (M-1s-1)
(4.5 ± 0.2) x 103
(5.7 ± 1.2) x 103
(2.0 ± 1.3) x 103
kcat/KM (M-1s-1)
(2.7 ± 0.5) x 106
(2.2 ± 0.7) x 106
(7.7 ± 1.5) x 105

While the measurements performed by Noh et al. were made following a different
assay, they both used the formation of CoA-SH to track reaction progress. While there
are noticeable differences between KM values, this is roughly maintained below a 10-fold
difference between the two variants. However, the rate of catalysis is severely affected.
Recorded kcat values are decreased 100 to 400-fold in the longer TcAANAT1 variant. It is
apparent that extension of the N-terminus of the enzyme is of serious detriment to the
catalytic efficiency of the enzyme. This is through either reducing the binding capacity of
acetyl-CoA, or slowing down the rate of product formation, rather than by preventing the
amine substrate from binding.
In addition to the catalyic differences between substrates active with both
enzymes, a discrete set of amines from the screening assay were found to be active for
TcAANAT1b. Serotonin, 2-phenethylamine, 2,2-difluoro-2-phenethylamine and histamine
were not demonstrated to show activity for TcAANAT1 but were substrates for
TcAANAT1b. While a full list of amines tested is not available for TcAANAT1, which
therefore makes it difficult to rule out activity for all listed above, the difference in activity
demonstrates the two enzymes each have very different catalytic capabilities.
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3.2.3 Acyl-CoA steady-state kinetic constants
To examine the capacity of TcAANAT1b to acylate, a full panel of acyl-CoAs were
tested for activity while holding the concentration of histamine constant. Histamine was
selected because many of the other substrates (namely the catecholamines) were found
to have an inhibitory effect at relatively low concentrations. The full panel of acyl-CoAs
tested included acetyl-CoA, butyryl-CoA, decanoyl-CoA, palmitoyl-CoA, stearoyl-CoA,
oleoyl-CoA, linoleoyl-CoA, arachidonyl-CoA, malonyl-CoA and benzoyl-CoA.
Table 3.4: Steady-state kinetic constants of acyl-CoA substrates for TcAANAT1b. Kinetic
constants were measured using 300 mM Tris-HCl, pH 8.0, 375 µM DTDP, and 5 mM
histamine
Substrate
Acetyl-CoA
Butyryl-CoA
Decanoyl-CoA

KM (μM)
65 ± 9.8
45 ± 4.9
6.7 ± 0.8

kcat (s-1)
52 ± 2.5
14 ± 0.5
3.4 ± 0.1

kcat/KM (M-1s-1)
(8.0 ± 0.1) x 105
(3.1 ± 0.4) x 105
(5.1 ± 0.6) x 105

As shown in Table 3.4, activity was found only from acetyl-, butyryl-, and decanoylCoA, demonstrating that TcAANAT1b is exclusively a short-chain acylator, with acetylCoA functioning as the endogenous acyl-donor. Comparison between the two TcAANAT1
variants is not possible with regards acyl-CoA kinetic constants as no such recordings
were made for TcAANAT1. In general, iAANATs show much less promiscuity with regards
the acyl-CoA substrate. Activity among iAANATs characterized has routinely been shown
from acetyl- to decanoyl-CoA with only a small selection demonstrating long-chain
acylation. While a decreasing KM compensates for a significantly lowered kcat, it appears
the amine binding pocket becomes blocked if the acyl chain is beyond a certain length.
For this reason, it could be assumed that TcAANAT1 shows a similar selection of acylCoA substrates as its truncated variant.
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3.2.4 Importance of the AANAT N-terminus
The reasons for the significant increase in catalytic efficiency upon truncation of
TcAANAT1 are as of yet unknown. As shown in Figure 3.1 (underlined), the catalytic site
of the amine binding pocket is often located relatively close to the start of the N-terminus
in AANATs.
While no crystal structure has been obtained for TcAANAT1, several other iAANAT
crystal structures do exist; from T. castaneum (TcAANAT0 – Discussed in Chapter 4), D.
melanogaster (DmAANATA),38 and A. aegypti (AaNAT2, AaNAT5b and AaNAT7),39 as
well as mammalian SNAT.40,41 SNAT has the longest N-terminus before amine binding
pocket, approximately 60 residues long. The conserved structure of this N-terminus is a
β-sheet which then forms an α-helix and makes up part of the amine binding pocket. This
binding motif begins at residue 70 in TcAANAT1. It is possible that some conformational
change is important at this particular motif to either facilitate acetyl-CoA binding or product
formation and release in this enzyme.
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Figure 3.1: Sequence alignment of AANAT1 (NCBI reference: XP_972873.2),
AANAT1b (NP_001139379.1) and AANAT0 (XP_972873.2) from Tribolium castaneum,
as well as AANATA (NP_523839.2) from Drosophila melanogaster
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Despite the existence of several insect AANAT structures with ligands bound, no
apo-structure has yet been obtained. So, to examine the conformational changes
associated with acetyl-CoA binding, the apo and holo structures for SNAT were
compared. It is interesting to note that upon acetyl-CoA binding to SNAT, much (~95%)
of the structure retains its basic shape except for the N-terminus which undergoes a
significant change. A motif stretching from 51 to 67 is a disordered region in the unbound
form of SNAT which stretches into the yet unformed amine binding pocket. Upon acetylCoA binding, this organizes into the amine pocket α-helix. This is apparent upon structural
alignment of free SNAT (PDB: 1B6B)41 with that bound to the bisubstrate analog CoA-Sacetyl-5-bromotryptamine (PDB: 1KUV)40 (Figure 3.2). The structural similarities between
AANATs implies that a similar mechanism possibly takes place in iAANAT. The extension
of the N-terminus in TcAANAT1 may have a detrimental effect on this conformational
shift. To examine this further, a crystal structure of the bound and unbound forms of
TcAANAT1 must be obtained.
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Figure 3.2: Structure of SNAT with (pink/red) and without (green/blue) bisubstrate
analog bound. The blue and red motifs represent residues 51-67 which undergo
significant organization upon initial substrate binding.
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3.3

Conclusion
Through the use of a well-validated and cost-effective screening assay, we have

demonstrated the ability to quickly identify and characterize differences in kinetic ability,
not just between different N-acetyltransferases, but between seemingly identical variants
of the same N-acetyltransferases. This process allows us to quickly answer the basic
questions of catalytic efficiency and begin the process of understanding the intrinsic
differences in structure and chemical mechanism which are the root origin for these
differences. Using these methods, we have shown that the truncated variant of
TcAANAT1 is a much more catalytically active form of the enzyme. As is often the case
for alternative splicing, this is potentially a method to control the rate of acetylation of
biogenic amines. In this sense, excess substrate or a scarcity of product results in an
upregulation of the truncated form of the enzyme. These findings give further credence
to the heterogeneity of insect AANATs.
3.4

Materials and methods

3.4.1 Cloning of TcAANAT1b
The codon-optimized TcAANAT1b gene (accession no. NP_001139379.1) was
synthesized by Genscript and ligated using New England Biolabs Quick Ligation™ kit into
a pET-28a vector using XhoI and NdeI restriction enzymes. The vector was transformed
into E. coli BL21(DE3) competent cells for subsequent protein expression. The
transformed cells were cultured at 37°C in 20g/L LB media, supplemented with kanamycin
(50 μg/mL) until an OD600 of 0.6 was achieved. Protein expression was induced with the
addition of 1.0 mM isopropyl β-D-1-thiogalactopyranoside (IPTG), and the culture was left
at 30°C for 5 hours. The cultures were then centrifuged at 5000 x g for 10 min at 4 °C and
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the resulting pellet was resuspended in 20 mM Tris, pH 8.0, 500 mM NaCl, and 5 mM
imidazole. The cells were lysed via sonication and centrifuged at 10,000 x g for 20 min at
4°C. The supernatants containing the N-terminal His6-tagged TcAANAT1b was collected
and left rocking in 6 mL of HisPur nickel-nitrilotriacetic acid (Ni-NTA) chelating resin. The
resin with the bound protein was then added to a column and charged with 10 column
volumes (CVs) of 20 mM Tris, pH 8.0, 500 mM NaCl, and 5 mM imidazole followed by a
wash of 20 CVs of 20 mM Tris, pH 8.0, 500 mM NaCl, and 60 mM imidazole. The purified
TcAANAT1b was eluted in 1.0 mL fractions with 20 mM Tris, pH 8.0, 500 mM NaCl, and
500 mM imidazole. The protein concentration in each fraction was measured using the
Bradford assay and the protein dialyzed for 16 hours at 4°C against 20 mM Tris pH 7.9,
200 mM NaCl. Following dialysis, the samples were assayed again for concentration and
the purity was assessed via SDS-PAGE gel. Purity was determined to be ≥95%
continuously for both proteins.
3.4.2 Screening assay
Once the protein was isolated, we began investigating an array of amine
substrates available as well as to determine if the enzyme can perform short (acetyl –
decanoyl), and long-chain (lauryl – arachidonoyl) acylation. To do this, we catalogued
each primary amine available to us, totaling about 90 primary amines. To test these one
by one would be time and resource consuming. Instead, each was categorized and
pooled in groups of four based primarily on their molecular weight and chemical
classification. For example, aminoglycosides were contained in one pool, while
catecholamines were similarly pooled together. The final concentration of each amine in
the pooled solution was kept constant at 100 mM.
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The N-acyltransferase driven acylation of an amine results in two products, the Nacylamide and coenzyme A (CoA-SH). CoA-SH formation can be quantified
spectrophotometrically using a reporter molecule with the ability to detect free thiols in
biological solutions. 5,5’-dithiobis-(2-nitrobenzoic acid), the well-known Ellman’s
reagent,35 has classically been used in this manner. However, more recent studies have
used 4,4’-dithiodipyridine (DTDP), noting its greater sensitivity.36 The in vitro formation of
CoA-SH results in reduction of the disulfide bond of DTDP to the corresponding
thioketone (Ɛ = 19,800 M-1cm-1 at pH 8.0),36 the rate of which can be measured at 324
nm (Figure 3.3).

Figure 3.3: Reaction of CoA-SH with 4,4’-dithiodipyridine producing a conjugated
thioketone detectable at 324 nm (Ɛ = 19,800 M-1cm-1 at pH 8.0)
To perform the screening assay, each pool was tested individually at 30°C, with a
saturating amount of either acetyl-CoA (short chain: 2 carbons) or oleoyl CoA (long chain:
18 carbons) present. A reaction volume of 750 μL was made up with 300 mM Tris (pH
8.0), 375 μM DTDP, 250 μM acetyl/oleoyl CoA, and 20 mM of the screening pool. The
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reaction was initiated with 320 nM of enzyme and the rate of change of absorbance per
second was recorded.
While a clear hit is apparent with this assay, a statistical parameter for the
evaluation and validation of the results is necessary, especially when approaching the
threshold for what may or may not be subjectively considered a hit. A simple method for
this is to measure the background rate of hydrolysis of the acyl-CoA and set a standard
of 10x that rate for what quantifies a hit. To validate this assay further, we measured the
ratio of the separation band to the signal dynamic range of the assay. Also known as the
Z-factor,37 this measurement is rudimentarily used to determine the viability of an assay
for high-throughput screening. However, we found that it was equally viable in
determining a hit from a pool of substrates. A score between 0.5 and 1 indicates a pool
that merits further examination. Any value below 0.5 can be considered to not be a hit.
This is shown in Equation 3.1, where σS and σC denote the sample and background signal
standard deviation across several replicates, and x̄S and x̄C denote the sample and
background signal means across several replicates. A control measurement for this assay
is important because unavoidable hydrolysis of the acyl-CoA substrate in solution leads
to a slight, but consistent rate of CoA-SH formation.
Equation 3.1
𝑍 =1−

(3𝜎𝑠 + 3𝜎𝐶 )
|𝐱̄𝑠 − 𝐱̄𝐶 |

A ‘hit’, which constituted a successful screen, saw the individual reagents tested
one by one using the same conditions previously mentioned to find the amine(s)
responsible for the positive result. This test was repeated for all the screens until a panel
of substrates was gathered. From here, individual kinetic parameters were measured
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using the same spectrophotometric technique, and varying substrate concentration. This
method was also used in a similar fashion to test varying acyl chain lengths by holding
the concentration of histamine constant, then testing a range of acyl-CoAs to see if any
long-chain acyl-CoAs, branched-CoAs, carboxylic-CoAs, or benzylated-CoAs act as
donor substrates.
3.5
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CHAPTER FOUR:
CHARACTERIZATION OF AANAT FROM TRIBOLIUM CASTANEUM:
A POTENTIAL NEXT-GENERATION INSECTICIDE TARGET

4.1

Introduction
The agricultural industry relies extensively on pesticides in an effort to prevent

destruction of field crops and stored crops. The increased demand for crop protection
through pesticide application is expected to drive the global agrochemicals market to
$308.92 billion by 2025.1 The issue of pesticide resistance, however, has meant that as
a species develops ways to negate the effects of a pesticide, an increased dose must be
applied.2 While it is argued that high doses are necessary for complete control over a
crop,3,4 this has led to these chemicals entering our food supply at dangerous levels,
many of which are known or probable carcinogens,3,8 harming not just mammals,7,8 but
also important pollinating species such as the honey bee.9–11 With regards to insect
control, many novel insecticides have entered the market with lower toxicity and higher
selectivity;12,13 however, their low polypharmacology classically means they are not as
economically viable as commercial insecticides, potentially leading to an increased rate
of resistance development.14
To combat insecticide resistance, a combination of (1) mixing, rotating, and
mandatory breaks in use of currently marketed insecticides, (2) continued design of novel
insecticides, and (3) identification of novel enzymatic targets for insecticides must be
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utilized. A thorough understanding of the mechanism of action of a potential new target
will enable the development of inhibitors that will target just one, or a select group of
enzymes within a specific insect pest. This will reduce the negative secondary effects on
mammals and/or pollinators.
Arylalkylamine

N-acyltransferase

(often

denoted

arylalkylamine

N-

acetyltransferase – AANAT) has shown potential as a novel insecticide target.15,16 These
enzymes catalyze the transfer of an acyl group from an acyl-CoA donor to a primary
amine acceptor: R1-NH2 + R2-CO-S-CoA → R2-CO-NH-R1 + CoA-SH. This reaction is
synonymous with gene transcription regulation via histone acetylation (histone
acetyltransferase – HAT),17,18 mammalian circadian rhythm maintenance via serotonin
acetylation (serotonin N-acetyltransferase – SNAT), 19,20 and dopamine acetylation, a key
step in insect cuticle sclerotization and melanism (dopamine N-acetyltransferase –
DAT).21–25 Additionally, insects lack monoamine oxidase, a regulatory enzyme which
facilitates the inactivation and excretion of monoamine neurotransmitters such as
dopamine and norepinephrine.26 AANAT is one of a group of enzymes proposed to
perform this role in insects.27,28 Recent evidence also suggests that AANATs have a role
in the biosynthesis of long-chain fatty acid amides in insects.29,30
As opposed to mammal and avian genomes, where only one AANAT has been
identified (SNAT),19,31 insects contain several iAANATs and iAANAT-like (iAANATL)
enzymes, perhaps, resulting from the wide range of functions ascribed to the iAANATs in
vivo. For example, Drosophila melanogaster and Aedes aegypti have at least eight and
thirteen iAANATs/iAANATLs, respectively.32,33 Notably, sequence identity between the
iAANATs/iAANATLs is most often <40%.34 The low sequence homology combined with
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the variety of cellular functions of the iAANATs/iAANATLs suggests that these enzymes
are excellent targets for novel insecticide design.17,18
Thorough insight on the mechanistic and structural characteristics of an iAANAT
will foster the development of a specific insecticide targeted against that enzyme. This
information will allow us to predict structural features that can be built into a putative
inhibitor, and to predict how an enzyme may naturally evolve resistance to the inhibitor.
Herein, we present an analysis of one iAANAT from Tribolium castaneum, one of the most
common secondary pests that infest and destroy stored grain products worldwide. To
date, insecticides such as phosphine, cyanogens, chloropyrifos, and malathion have
shown limited success at negating the damage caused by T. castaneum.35–38 These
pesticides are not viable long-term solutions for T. castaneum control because of
emerging resistance (especially in developing countries) and the detrimental effects these
have on the environment.39
Previous work on iAANATs has significantly expanded our understanding of the
structure and mechanisms (kinetic and chemical) of these enzymes; however, we are
only now beginning to appreciate their variability. Our data show that T. castaneum
iAANAT continues this trend of heterogeneity with respect to kinetic and chemical
mechanism,

substrate

specificity,

and

structure/function

characteristics.

These

appreciable differences highlight the individuality of each AANAT, not just from insect to
insect, but also from isoform to isoform within each insect.
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4.2

Results and discussion

4.2.1 Acyl-CoA steady-state kinetic constants
A panel of twelve acyl-CoAs were selected to test for activity with TcAANAT0:
acetyl-, propionyl-, butyryl-, DL-β-hydroxybutyryl-, crotonyl-, and decanoyl-CoA all
represented short-chain acyl-CoAs. DL-β-hydroxybutyryl CoA and crotonyl CoA were
used to examine the effect of β-hydroxylation and desaturation on activity respectively.
Palmitoyl, stearoyl- and oleoyl-CoA all represented long-chain acyl-CoAs. Finally,
malonyl-CoA and succinyl-CoA represented carboxylate-containing CoAs, and benzoylCoA represented an aryl CoA. Short-chain acyl-CoAs were substrates for TcAANAT0
(Table 4.1), while the long-chain acyl-CoAs and malonyl-CoA were not. Weak activity was
also seen for succinyl-CoA, and benzoyl-CoA. Butyryl-CoA was shown to have an ~160fold decrease in activity when β-hydroxylated but only a 3-fold decrease when
unsaturated. Hydroxylation had the greatest effect on acyl-CoA binding, with the main
reason for the loss in activity being a sharp increase in KM. Interestingly, a trend of steadily
decreasing KM values from acetyl- to decanoyl-CoA was observed, which hints at an
active site capable of accepting and binding to longer chain CoAs.
We have observed a similar trend for iAANATs from Drosophila melanogaster and
Bombyx mori.40,41 However, the decreasing kcat value as the length of the acyl chain
increases implies that catalysis is not feasible for long-chain acyl-CoA substrates. This
likely results from the amine binding pocket becoming sterically occupied upon long-chain
acyl-CoA binding, preventing either (a) the amine from binding, (b) the occurrence of a
catalytically important conformational change, or (c) improper positioning of the
substrates within the active site. Further investigation is needed to uncover the
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evolutionary and structural divergencies that differentiate iAANATs that accept shortchain acyl-CoAs as substrates from those that accept long-chain acyl-CoA as substrates
such as DmAANATL2 and Bm-iAANAT.29,30 This phenomenon is discussed further in
Chapter 6.
Table 4.1: Steady-state kinetic constants of active acyl-CoA substrates for TcAANAT0.
Kinetic constants were measured using 300 mM Tris-HCl, pH 8.0, 375 µM DTDP, and 5
mM tryptamine.
Substrate
Acetyl-CoA
Propionyl-CoA
Butyryl-CoA
Crotonyl-CoA
DL-β-hydroxybutyryl-CoA
Decanoyl-CoA
Succinyl-CoA
Benzoyl-CoA

KM (μM)
25 ± 1.8
21 ± 2.1
15 ± 1.8
29 ± 3.5
(1.0 ± 0.4) × 103
0.9 ± 0.2
(6.8 ± 1.4) × 102
48 ± 6.5

kcat (s-1)
29 ± 0.6
17 ± 0.5
5.5 ± 0.1
3.3 ± 0.2
2.3 ± 0.5
0.8 ± 0.1
1.1 ± 0.1
0.04 ± 0.01

kcat/KM (M-1s-1)
(1.2 ± 0.1) × 106
(8.0 ± 0.8) × 105
(3.7 ± 0.5) × 105
(1.1 ± 0.2) × 105
(2.3 ± 0.1) × 103
(9.6 ± 2.2) × 105
(1.6 ± 0.3) × 103
(9.3 ± 1.3) × 102

4.2.2 Amino steady-state kinetic constants
A panel of >40 amines were screened against acetyl- and oleoyl-CoA to establish
the amine substrate specificity and to determine if the length of the acyl-chain of the acylCoA substrates influences the specificity for the amine. A modified version of the strategy
described by Dempsey et al.41 and expanded upon in Chapter 2 was employed to
evaluate the amines as TcAANAT0 substrates. The amines used in the screening
strategy included amino acids, an array of biogenic catecholamines and indolamines,
polyamines, and aminoglycosides. We also included amines with a pKa <8.0, i.e. amines
that will possess a deprotonated amine group at the pH used for our screening assay (pH
8.0). Those amines demonstrating activity above the baseline activity level resulting from
the non-enzymatic hydrolysis of the acyl-CoA substrate were analyzed to determine their
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kinetic constants. No activity was observed for any of the amines with oleoyl-CoA as the
acyl donor; however, activity was found for 10 amines paired with acetyl-CoA,
summarized in Table 4.2. The promiscuity of TcAANAT0 compared to the putative T.
castaneum DAT previously studied by Noh et al.42 indicated a more functionalized
enzyme, providing a unique insight into AANAT activity.
Table 4.2: Steady-state kinetic constants of most active amine substrates for TcAANAT0.
Kinetic constants were measured using 300 mM Tris-HCl, pH 8.0, 375 µM DTDP, and
250 µM acetyl-CoA
Substrate
2-Phenethylamine
Dopamine
2,2’-Difluoro-2-phenethylamine
DL-Norepinephrine
Serotonin
Histamine
Tryptamine
Tyramine
Agmatine
Octopamine

KM (μM)
140 ± 18
140 ± 11
340 ± 46
480 ± 46
480 ± 77
1,700 ± 170
260 ± 29
520 ± 61
1,200 ± 110
2,500 ± 140

kcat (s-1)
100 ± 8.1
61 ± 1.3
78 ± 4.5
53 ± 1.8
35 ± 2.0
57 ± 1.7
33 ± 0.8
36 ± 1.3
77 ± 3.0
43 ± 0.8

kcat/KM (M-1s-1)
(7.1 ± 1.1) × 105
(4.4 ± 0.3) × 105
(2.3 ± 0.3) x 105
(1.1 ± 0.1) x 105
(7.4 ± 0.1) x 104
(3.4 ± 0.4) x 104
(9.2 ± 0.8) x 104
(7.0 ± 0.8) x 104
(6.4 ± 0.6) x 104
(1.7 ± 0.1) x 104

4.2.3 Product characterization
The assay we employed to measure activity was dependent upon the release of
free CoA-SH.43 Thus, the data of Table 4.1 and 4.2 do not exclude the possibility of an
amine-activated thioesterase activity for TcAANAT0. Mass spectrometry was used to
characterize the product (N-acetyltryptamine) and confirm TcAANAT0 was indeed
synthesizing acylated amines. The retention times and high-resolution mass-to-charge
ratios of the enzyme product and the commercial standard are shown in Table 4.3 to
validate the catalytic product of the enzyme. A no-enzyme control was used to confirm
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the thermodynamic formation of N-acetyltryptamine was not occurring independent of the
enzyme catalyst at the same rate.
Table 4.3: TcAANAT0 product characterization. Assay conditions – 300mM Tris, pH 8.0,
1mM acetyl-CoA, 1mM tryptamine,100 μg TcAANAT0.
Sample
TcAANAT0 assay
N-Acetyltryptamine standard
No-enzyme control

Retention Time (min)
3.445
3.487
3.433

m/z
203.1187
203.1188
203.1182

Intensity
266,055.84
4,096,377.28
1,498.61

4.2.4 TcAANAT0 kinetic mechanism
The kinetic mechanism for TcAANAT0 was examined using a combination of initial
kinetics analysis, dead-end inhibition, and direct ligand binding by isothermal titration
calorimetry. A kinetic fingerprint for an ordered mechanism was obtained by varying the
concentration of acetyl-CoA at different fixed concentrations of tryptamine (Figure 4.1);
the data was best fit to an ordered bi-bi mechanism. Our results eliminate the possibility
of a random mechanism, which has been attributed to several AANATs previously.40,44
Catalysis, in the case of TcAANAT0, involves the initial binding of acetyl-CoA and only
takes place after the formation of a TcAANAT0•acetyl-CoA•tryptamine ternary complex.
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A

B

Figure 4.1: Acetyl-CoA and tryptamine initial velocity double reciprocal plots. (A)
Velocities measured at fixed concentrations of tryptamine: 720 μM (), 360 μM (),
125 μM (), 75 μM () and 50 μM (). (B) Velocities measured at fixed
concentrations of acetyl-CoA: 100 μM (), 37 μM (), 20 μM (), and 10 μM ().
These data are best fit to the rate equation for a sequential mechanism
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Isothermal titration calorimetry was used to confirm the binding of acetyl-CoA to
the enzyme (Figure 4.2). We found that acetyl-CoA binds to free TcAANAT0 with a Kd
vaule of 0.33 ± 0.04 μM. This is in good agreement with the Kd obtained for acetyl-CoA
from Bm-iAANAT3 of 0.66 ± 0.03 μM.45 The considerable enthalpic contribution (ΔH = 9.49 ± 0.13 kcal/mol) and unfavorable entropic contribution (-TΔS = 0.639 kcal/mol)
indicate that binding of acetyl-CoA significantly stabilizes the structure of TcAANAT0. This
is in agreement with the ITC measurements for the binding of acetyl-CoA to
DmAANATA.46

Figure 4.2: ITC measurements of acetyl-CoA binding to TcAANAT0. Titrations included
an initial 0.2 μl injection and 12 subsequent injections of 500 μM acetyl-CoA into 40 μM
TcAANAT0, with a 3 min time interval between injections.

Next, to determine the order of substrate binding and product release, a set of
dead-end inhibition experiments was performed. The substrate analogs desulfo-CoA and
tryptophol were used as dead-end inhibitors. Inhibition constants were measured for all
compounds. The data are summarized in Table 4.4 where KI,s is the inhibition constant
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affecting the slope (when I binds to E), and KI,i is the inhibition constant affecting the
intercept (when I binds to ES). The inhibition patterns for desulfo-CoA, competitive vs.
acetyl-CoA and non-competitive vs. tryptamine (Figure 4.3), and for tryptophol,
competitive vs. tryptamine and uncompetitive vs. acetyl-CoA (Figure 4.4), confirm an
ordered sequential mechanism for substrate binding, with acetyl-CoA binding first.
Product inhibition was attempted with N-acetyltryptamine, but no inhibition was detected
at a concentration as high as 10 mM. N-Acetylagmatine was also evaluated as a product
inhibitor. However, with a measured IC50 >50 mM, the acetylated amine products simply
do not bind to the free form of the enzyme, suggesting a conformational change upon
acetyl-CoA binding. This conformational change has been shown previously in Bombyx
mori iAANAT to facilitate interaction with the incoming amine.45 The lack of inhibition from
our product analogs means determination of product release order was difficult. However,
ordered product release with the N-acetylamine being released first and free CoA-SH
being released second has been observed for other iAANATs and is consistent with both
the lack of any appreciable binding of the N-acetylamines to free enzyme, and the ability
of desulfo-CoA to do so.41
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Table 4.4: Inhibition patterns observed for inhibitors of the amine binding pocket
(tryptophol) and acyl-CoA binding pocket (desulfo-CoA). Kinetic constants were
measured with varied tryptamine concentrations of 50, 75, 100, 150, 300, and 500 µM
and fixed 50 µM acetyl-CoA. Acetyl-CoA concentrations were varied at 10, 20, 30, 50, 80,
and 100 µM with fixed 300 µM tryptamine. Tryptophol concentrations were varied at 0, 2
and 4 mM. Desulfo-CoA concentrations were varied at 0, 0.5, and 2 mM.
Inhibitor
Desulfo-CoA
Tryptophol

Varied Substrate
Tryptamine
Acetyl-CoA
Tryptamine
Acetyl-CoA

Inhibitor Pattern
NC
C
C
UC

KI,s (mM)
1.1 ± 0.2
0.3 ± 0.03
2.2 ± 0.1
--

KI,i (mM)
0.6 ± 0.07
--4.0 ± 0.2

Figure 4.3: Inhibition patterns observed for desulfo-CoA for the amine binding pocket
(left) and acyl-CoA binding pocket (right).

Figure 4.4: Inhibition patterns observed for tryptophol of the amine binding pocket (left)
and acyl-CoA binding pocket (right).
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Finally, we interrogated the TcAANAT0-catalyzed reaction using the bisubstrate
analog, CoA-S-acetyltryptamine as an inhibitor. Inhibition plots resulted in competitive
and non-competitive apparent KI values of 25 ± 1.9 μM and 120 ± 3.7 μM against acetylCoA and tryptamine respectively (Figure 4.5). However, the observance of multiple rates
of product formation, rather than one initial steady-state rate followed by a plateau
indicated slow-binding inhibition. We measured the rate of product formation for four
concentrations of inhibitor (20, 30, 100 and 200 μM), across a time frame where a steadystate rate is observed in the absence of inhibitor (30 sec) (Figure 4.6). The true KI value
(KItrue) was found to be 16 ± 1.7 μM following the methods of Schlesinger et al.47 and
Merkler et al.48 (see Section 4.4.4). The mechanism of inhibition is shown in Figure 4.7
and the data summarized in Table 4.5.

Figure 4.5: Inhibition patterns observed for CoA-S-acetyltryptamine. Kinetic constants
were measured with varied tryptamine concentrations of 50, 75, 100, 150, 300, and 500
µM and fixed 50 µM acetyl-CoA. Acetyl-CoA concentrations were varied at 10, 20, 30,
50, 80, and 100 µM with fixed 300 µM tryptamine. CoA-S-acetyltryptamine
concentrations were varied at 0, 100 and 250 µM.
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The time-dependence in the inhibition of this bisubstrate analog indicates a
structural reorganization upon formation of the intermediate. This is akin to a kinetic
proofreading mechanism, wherein the active site affinity for the substrates increases upon
intermediate formation, slowing the reaction down and assuring correct product
formation.49

B
A

C

Figure 4.6: Time-dependent inhibition of TcAANAT0 by CoA-S-acetyltryptamine. (A)
Plot of progress curves of TcAANAT0 saturated with acetyl-CoA and tryptamine and
with varying concentrations of inhibitor. (B) Activity regeneration of TcAANAT0 after 10minute incubation with inhibitor compared against no-incubation control. (C) Plot of kobs
vs. [I].
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Table 4.5: Summary of kinetic rate and inhibition constants attributed to time-dependent
inhibition

Kinetic Parameter
k5app (M-1 s-1)
k5true (M-1 s-1)
k6 (s-1)
Half-life (τ) (s)
KI,app, acetyl CoA (μM)
KItrue (μM)

(7.2 ± 1.1) × 101
(7.9 ± 1.2) × 102
(1.2 ± 0.02) × 10-2
83 ± 1.2
25.3 ± 1.9
16.2 ± 1.7

Figure 4.7: Kinetic model for slow-binding inhibition. Initial inhibitor binding (k3) is
followed by a second slower step (k5) induced by a structural reorganization. KItrue is
defined by the ratio of k5 and k6, the relative formation and relaxation of EI*, the maximally
inhibited complex.
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4.2.5 Crystal structure and mutagenesis of TcAANAT0
In order to get a better structural understanding of TcAANAT0, we attempted to
crystalize the apo protein. However, crystallization efforts with the apo TcAANAT0 proved
unsuccessful after several attempts. We next attempted to co-crystallize TcAANAT0 with
acetyl-CoA, in the hopes that the acetyl-CoA could stabilize the protein enough to allow
for crystal formation. The crystal structure of TcAANAT0 in complex with acetyl-CoA was
determined at 2.84 Å resolution and belongs to the C2 space group. The crystal has six
copies of TcAANAT0 in the asymmetric unit, with each copy bound to acetyl-CoA. The
Fo-Fc electron density for acetyl-CoA is well-defined with the exception of the pantetheine
tail, where the density is weaker than the rest of the compound. The adenine portion of
acetyl-CoA forms a prominent stacking interaction with Phe-166 and another acetyl-CoA
present in an adjacent TcAANAT0 molecule (Figure 4.8). Notably, no other AANAT
structure has shown such an interaction, highlighting the heterologous nature of
iAANATs. Creation and analysis of the F166A mutant illustrated the functional importance
of this residue, as the F166A mutant is a catalytically inert form of the enzyme (Table 4.6)
These stacking interactions between adjacent acetyl-CoA molecules, and Phe-166, likely
served to stabilize the lattice and helped to induce crystal formation. This possibility is
further evidenced by the lack of crystal formation when TcAANAT0 was not co-crystallized
with acetyl-CoA.
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Figure 4.8: Crystal Structure of TcAANAT0 in complex with acetyl-CoA. The complex xray crystal structure of TcAANAT0 in complex with acetyl-CoA is shown at 2.84 Å
resolution. The unbiased Fo-Fc electron density map is contoured at 3σ and shown in
green. TcAANAT0 is colored in magenta, and acetyl-CoA is colored in orange. Hydrogen
bonds are shown as black dashed lines.

Further examination of the binding of acetyl-CoA to TcAANAT0 demonstrates
favorable interactions with multiple active site residues (Figure 4.9). Specifically, the three
phosphates in acetyl-CoA form several potential hydrogen bonds with the TcAANAT0
backbone in the area from Gly-135-Lys-140, as well as with the Lys-140 side chain. The
pantothenic acid portion of acetyl-CoA also establishes extensive interactions with the
active site. Notably, Arg-134 forms a hydrogen bond with acetyl-CoA, in addition to van
der Waals interactions between the acetyl-CoA geminal methyl groups and the Arg-134
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side chain. Arg-134 aligns with Arg-153 of DmAANATA41, Arg-138 of DmAANAT250, and
Arg-138 of DmAANAT751, which have been shown to be important in maintaining the
structure of the acyl-CoA binding pocket. Production of the R134A mutant of TcAANAT0
confirmed this, with a 94% and 88% drop in catalytic efficiency for acetyl-CoA and
tryptamine. A 15-fold increase in KM and preservation of kcat for acetyl-CoA is testament
to the structural rather than catalytic importance of Arg-134 (Table 4.6).

Figure 4.9: Structure of acetyl-CoA binding interactions within the TcAANAT0 active
site. Acetyl-CoA is shown in pink and interacting residues shown in gray.
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Sequence alignment with other characterized iAANATs also indicated that Glu-25 located
in close proximity to the amine binding pocket and the acetyl group of the bound acetylCoA holds catalytic relevance in TcAANAT0 (Figure 4.10). This is due to its correlation to
Glu-47 of DmAANATA,41 Glu-26 of DmAANAT7,51 Glu-34 of DmAgmNAT52 and Glu-27
in Bm-iAANAT3,40 which have all been shown to act as a general base during catalysis.

Figure 4.10: Primary sequence alignment showing conserved Glu residue (within amine
binding pocket motif DEPLN) attributed to functioning as a general base in insect
AANATs.

Kinetic analysis of an E25A mutant of TcAANAT0 was in similar agreement,
illustrated by a 92% and 98% drop in catalytic efficiency for acetyl-CoA and tryptamine
respectively. Surprisingly, production of an E25D conserved mutant yielded similar
results, with a 78% and 95% drop in catalytic efficiency recorded for acetyl-CoA and
tryptamine respectively (Table 4.6). It is interesting to note that shortening the length of
the residue R-group by one methylene group significantly deters the ability of the enzyme
to perform catalysis.
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Table 4.6: Steady-state kinetic constants for TcAANAT0 site-directed mutants. Kinetic
constants were measured in triplicate as previously described for the wild-type enzyme
Mutant
Wild-Type
E25A
E25D
R134A
F166A
Mutant
Wild-Type
E25A
E25D
R134A
F166A

KM (μM)
25.0 ± 1.8
12.0 ± 2.4
8.7 ± 1.8
394 ± 22
N/A

kcat (s-1)
29 ± 0.6
1.1 ± 0.1
2.3 ± 0.1
29 ± 0.7
N/A

KM (μM)
260 ± 29
751 ± 46
500 ± 68
1130 ± 75
N/A

kcat (s-1)
33 ± 0.8
1.40 ± 0.1
2.2 ± 0.1
12.8 ± 0.2
N/A

Acetyl-CoA
kcat/KM (M-1s-1)
(1.2 ± 0.1) x 106
(9.7 ± 2.1) x 104
(2.6 ± 0.5) x 105
(7.4 ± 0.4) x 104
N/A
Tryptamine
kcat/KM (M-1s-1)
(9.2 ± 0.8) x 104
(1.8 ± 0.1) x 103
(4.5 ± 0.6) x 103
(1.1 ± 0.1) x 104
N/A

% Effectiveness
100
3.8
22.1
6.3
0
% Effectiveness
100
4.1
4.8
12.2
0

4.2.6 TcAANAT0 chemical mechanism
To determine the chemical mechanism of TcAANAT0, the pH-dependence of
binding and catalysis was measured for tryptamine (Figure 4.11), 2,2-difluoro-2phenethylamine (DFPE) (Figure 4.12), and acetyl-CoA (Figure 4.13). Rate profiles
allowed the determination of likely catalytic or structurally important residues based on
their apparent pKa values. The fits produced profiles with three ionizable groups involved
in binding and/or catalysis (Table 4.7). An acidic pKa of approximately 7.3 was attributed
to a general base, which has classically been found in iAANATs.41,50,53 The exact function
of this general base has been argued, but it has been proposed that deprotonation of the
amine occurs prior to formation of a tetrahedral intermediate.41 To investigate this, rate
profiles were generated for 2,2’-difluoro-2-phenethylamine (DFPE; predicted pKa ≈ 6.7 ±
0.3 – calculated via SciFinder using Advanced Chemistry Development (ACD/Labs)
Software 11.02). The disappearance of the acidic limb when measuring kcat against pH
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highlights that at pH levels of 6 to 8, where DFPE is still largely found in its deprotonated
form (when compared to tryptamine, pKa ≈10.2),54 the function of the general base is
negated.

Figure 4.11: pH rate profiles for tryptamine illustrating the effect of pH on kcat, and
kcat/KM.

Figure 4.12: pH rate profiles for DFPE illustrating the effect of pH on kcat, and kcat/KM.

Figure 4.13: pH rate profiles for acetyl-CoA illustrating the effect of pH on kcat, and
kcat/KM.
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A second pKa of approximately 9.0 was also observed, with evidence indicating
two unresolvable species are involved. The first of these can likely be attributed to the
thiol group of the departing CoA-SH, which has a reported pKa ≈ 10.2.54 This pKa has also
been attributed to a general acid, which facilitates the release of the products. However,
after careful examination of the TcAANAT0 crystal structure, there is no obvious active
site residue that might function as a general acid during catalysis. We propose rather than
a general acid actively involved in catalysis, a more likely scenario involves a residue,
upon amine binding, forming a hydrogen bond with the general base and acting as a
polarizer. This would stabilize the charge on the glutamate and increase its pKa, giving
credence to a glutamate performing a general base role.
Table 4.7: Summary of pKa values measured from pH rate profiles.
Acidic Limb pKa values

Basic Limb pKa values

kcat (s-1)

kcat (s-1)

Acetyl CoA

7.4 ± 0.1

Acetyl CoA

9.6 ± 0.3

Tryptamine

7.1 ± 0.2

Tryptamine

8.3 ± 0.2

DFPE

N/A

DFPE

8.7 ± 0.1

kcat / KM (M-1s-1)

kcat / KM (M-1s-1)

Acetyl CoA

6.5 ± 0.2

Acetyl CoA

8.7 ± 0.3

Tryptamine

7.9 ± 0.1

Tryptamine

9.3 ± 0.2

DFPE

7.5 ± 0.2

DFPE

8.6 ± 0.2
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We propose two plausible chemical mechanisms for TcAANAT0. In the first
mechanism (Figure 4.1), Glu-25 is the base responsible for the deprotonation of the
amine moiety of tryptamine, nucleophilic attack at the carbonyl of the thioester of acetylCoA generates a zwitterionic tetrahedral intermediate, and an unidentified general acid
acts to polarize Glu-25. Subsequent protonation of CoA-SH results in breakdown of this
intermediate in a time-dependent manner, as illustrated by the time-dependent inhibition
of TcAANAT0 by CoA-S-acetyltryptamine. This time-dependence also points to
intermediate collapse likely being the rate-determining step. Upon product release, this
‘acidic’ residue moves out of hydrogen bond range of the base, thereby relaxing the pKa
of the base resulting in its deprotonation and reformation of the enzyme active site. The

Figure 4.14: Proposed chemical mechanism for T. castaneum AANAT0 with an
unidentified general acid responsible for the identified pKa of 9.8.
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role of a general acid has been suggested for AANATs previously (as discussed in
Chapter 2), however, thus far, researchers have been unable to directly correlate one
residue to this role. It is possible that the acid has a passive, rather than active role in
catalysis. If the general acid is part of a motion after amine binding, it would stand that
the corresponding residue may not be obvious from crystal structures.

Figure 4.15: Proposed chemical mechanism for T. castaneum AANAT0 with the
departing CoA-SH responsible for the identified pKa of 9.8.

The second proposed mechanism (Figure 4.15) follows a very similar vein to that
proposed for other iAANATs.41,46,50,52 This mechanism differs only from that shown in
Figure 4.14 in that the pKa of 9.8 is solely attributed to the departing CoA-SH rather than

111

a general acid. Due to the data indicating two unresolvable pKa values ≈9.8, we favour
the former mechanism for TcAANAT0.
4.3

Conclusion
TcAANAT0, a previously uncharacterized AANAT from Tribolium castaneum, was

found to have significant promiscuity in both acyl-CoA donor and amine acceptor, as
opposed to the previously characterized TcAANAT1. The kinetic mechanism follows a
steady-state ordered mechanism, with acyl-CoA binding first. Generation of a crystal
structure of TcAANAT0 bound to acetyl-CoA allowed us to pinpoint some key features in
the enzyme active site, which, coupled with site-directed mutagenesis and pH-rate
profiling, allowed us to shine further light on the chemical mechanism of iAANATs. The
knowledge gained from such intrinsic understanding of the mechanistic and structural
relationship of iAANATs is invaluable in their development as insecticide targets.
Fragment-based drug discovery in the pursuit of AANAT-targeted inhibitors with insect
specificity are in progress.
4.4

Experimental procedures

4.4.1 Materials
Unless otherwise noted, all reagents were of the highest quality available from
commercial sources. Codon-optimized TcAANAT0 was purchased from Genscript.
Oligonucleotides were purchased from Eurofins MWG Operon. BL21 (DE3) E. coli cells,
XL-10 competent cells, and the pET-28a(+) vector were purchased from Novagen.
PfuUltra High-Fidelity DNA polymerase and the QuikChange Site-Directed Mutagenesis
Kit were purchased from Agilent. XhoI, NdeI, Antarctic phosphatase, and T4 DNA ligase
were purchased from New England Biolabs. Kanamycin monosulfate and isopropyl-β-D112

thiogalactopyranoside (IPTG) were purchased from Gold Biotechnology. ProBond nickelchelating resin was purchased from Invitrogen. Acyl-CoAs, N-acetyltryptamine, and the
amine substrates were purchased from Sigma-Aldrich. Desulfo-CoA was synthesized in
lab following the methods of Chase, et al.54 CoA-S-acetyltryptamine was synthesized in
lab following the methods of Khalil and Cole.55 Spectrophotometric analyses were
performed on a Cary 300 Bio UV-Visible spectrophotometer. Isothermal titration
calorimetry was performed on a VP-ITC calorimeter (GE Healthcare).
4.4.2 Cloning of T. castaneum AANAT0
The codon-optimized genes for T. castaneum AANAT0 (NCBI reference
sequence: XM_967780.4) was cloned, overexpressed and purified following the
procedure described in Chapter 3, Section 3.4.1.
Additional purification steps were necessary for crystallization. Following affinity
purification, the protein was dialyzed against a buffer of 50 mM Tris HCl, pH 8.0, and 10
mM CaCl2 in preparation for thrombin cleavage of the His6-tag. Protein (10 mg) was
incubated with thrombin agarose resin at 4°C for 24 hours following the recommended
procedure. The sample was then loaded onto a Ni-NTA column and the cleaved protein
eluted in 1 mL fractions with 20 mM Tris, pH 8.0, 500 mM NaCl, and 60 mM imidazole.
SDS-PAGE was used to check the purity of the eluted protein. The appropriate fractions
were combined and concentrated using a Millipore ultrafiltration cell. The concentrated
sample was further purified via FPLC using a SuperDex 75 gel filtration column. The
running buffer was 20 mM Tris pH 7.4, 50 mM NaCl, 1 mM EDTA, and 1 mM DTT and
the final purified protein was concentrated to 16.9 mg/mL.
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4.4.3 Determination of enzyme activity
4,4’-Dithiodipyridine (DTDP) was used to determine the activity of TcAANAT0 at
324 nm (molar absorptivity = 19,800 M-1cm-1)56 by measuring the formation of CoA-SH
product. Each 750 μL assay consisted of 300 mM Tris, pH 8.0, 375 μM DTDP, and the
desired concentration of acyl-CoA and amine substrates. Amine and acyl-CoA kinetic
constants were measured by holding the concentration of acetyl-CoA and tryptamine at
fixed, saturated levels (250 μM and 5 mM) respectively. Measurements were made in
triplicate using a Cary 300 Bio UV−visible spectrophotometer at 30 °C. Steady-state
kinetic parameters were evaluated by fitting initial velocity measurements to Equation 4.2
using Enzyme Kinetic Wizard (SigmaPlot 12.0).
Equation 4.2
𝑉𝑜 =

𝑉𝑚𝑎𝑥 [𝑆]
𝐾𝑀 + [𝑆]

4.4.4 Determination of kinetic mechanism
To fully define the kinetic mechanism of TcAANAT0, a combination of initial
velocity double-reciprocal analysis and dead-end inhibition was utilized. Firstly, initial
velocities were measured by varying the concentration of one substrate while holding the
other substrate at constant, but different concentrations. Measurements were made at
acetyl-CoA concentrations of 10, 20, 37, and 100 μM, and tryptamine concentrations of
50, 75, 125, 360, and 720 μM. The resulting data were fit to Equation 4.3 for an ordered
bi-bi mechanism (χ2 = 27.5) using Visual Enzymics 2010 (IGOR Pro 6.34 A).
Equation 4.3
𝑉𝑚𝑎𝑥 [𝐴][𝐵]
𝐾𝑖,𝑎 𝐾𝑀,𝑏 + 𝐾𝑀,𝑎 [𝐵] + 𝐾𝑀,𝑏 [𝐴] + [𝐴][𝐵]
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To further define the kinetic mechanism, tryptophol and desulfo-CoA were utilized
as dead-end inhibitors for tryptamine and desulfo-CoA respectively. Initial velocity
patterns were obtained by varying the concentration of one substrate, while holding the
concentration of the second at approximately the KM. This was then repeated twice in the
presence of fixed concentrations of inhibitor. To test inhibition of the amine binding site,
tryptophol was used as the inhibitor at 2.0 and 4.0 mM. To test inhibition of the acyl-CoA
binding site, desulfo-CoA was introduced as the inhibitor at 500 and 1000 μM.
Measurements were made at varying tryptamine and acetyl CoA concentrations of 50,
75, 100, 150, 300 and 500 μM, and 10, 20, 30, 50, 80 and 100 μM respectively. To
measure the steady-state inhibition of CoA-S-acetyltryptamine, measurements were
made at varying tryptamine and acetyl CoA concentrations of 50, 75, 100, 150, 300 and
500 μM, and 20, 30, 50, 80, 100 and 120 μM respectively and at 0, 100 and 250 μM CoAS-acetyltryptamine. The data were then fit to Equation 4.4, Equation 4.5, and Equation
4.6 using Enzyme Kinetic Wizard (SigmaPlot 12.0) to differentiate between competitive,
non-competitive, and uncompetitive inhibition.
Equation 4.4
𝑉𝑚𝑎𝑥 [𝑆]
𝐼
𝐾𝑀 (1 + ) + [𝑆]
𝐾𝑖𝑠

Equation 4.5
𝑉𝑚𝑎𝑥 [𝑆]
𝐼
1
𝐾𝑀 (1 + ) + [𝑆] (1 + )
𝐾𝑖𝑠
𝐾𝑖𝑖
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Equation 4.6
𝑉𝑚𝑎𝑥 [𝑆]
𝐾𝑀 + [𝑆] (1 +

1
)
𝐾𝑖𝑖

To measure the time-dependence of CoA-S-acetyltryptamine, the rate of reaction
was measured at 3 mM tryptamine and 250 μM acetyl-CoA. Enzyme concentration was
kept low to ensure the longest possible steady-state duration in the absence of inhibitor.
Consecutive measurements were then made at 20, 30, 100 and 200 μM CoA-Sacetyltryptamine. The resulting progress curves were fit using SigmaPlot 12.0 to Equation
4.7, where vi is the initial rate, and vf is the final rate in order to calculate kobs, the observed
first-order rate constant. The rate constant of dissociation, koff, was measured directly via
jump dilution. Enzyme at 40 μM was incubated for 10 min. with 250 μM of CoA-Sacetyltryptamine. After incubation, 1 μL of this mixture was then used to initiate the
reaction, resulting in a 750-fold dilution of inhibitor. These data were then fitted to
Equation 4.7, with vi measured as 1.0 μmoles/min and vf measured as 7.1 μmoles/min.
This allowed konapp to be estimated using Equation 4.8 under the assumption of
competitive inhibition against acetyl-CoA binding. A good fit indicated a one-step slow
binding mechanism. The resulting estimate, konapp was adjusted to account for substrate
competition using Equation 4.9 to give kontrue. Finally, the true inhibition constant, KItrue
was calculated using Equation 4.10.
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Equation 4.7
[𝑃] = 𝑣𝑓 𝑡 + (

(𝑣𝑖 − 𝑣𝑓 )
) (1 − 𝑒 −𝑘𝑜𝑏𝑠 𝑡 )
𝑘𝑜𝑏𝑠

Equation 4.8
𝑘𝑜𝑏𝑠 = 𝑘𝑜𝑛 𝑎𝑝𝑝 [𝐼] + 𝑘𝑜𝑓𝑓

Equation 4.9
𝑘𝑜𝑛 𝑡𝑟𝑢𝑒 = 𝑘𝑜𝑛 𝑎𝑝𝑝 (1 +

[𝑆]
)
𝐾𝑀

Equation 4.10
𝐾𝐼 𝑡𝑟𝑢𝑒 = 𝐾𝐼 𝑎𝑝𝑝 (

𝑘𝑜𝑓𝑓
𝑘𝑜𝑛 𝑡𝑟𝑢𝑒

)

4.4.5 Determination of acetyl-CoA binding constants
Isothermal titration calorimetry (ITC) was used to investigate the interaction
between acetyl-CoA and TcAANAT0. Experiments were performed on a VP-ITC
calorimeter (GE Healthcare) at 30°C and using. Following Ni-NTA affinity chromatography
purification, as described previously, TcAANAT0 was dialyzed overnight against 20 mM
Tris, pH 8.0, 100 mM NaCl, 0.5 mM EDTA and 1 mM tris(2-carboxyethyl)phosphine
(TCEP). Enzyme samples were then diluted to 40 μM and loaded into a 200 μL sample
cell. Acetyl-CoA samples of ~10-fold excess were prepared from the same dialysis buffer
and loaded into a 40 μL injection syringe. Titrations included an initial 0.2 μl injection and
12 subsequent injections of acetyl-CoA until completion, with a 3 min time interval
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between injections. The data were fit using Origin 7.0 (OriginLab Corporation) with the
point of initial injection excluded and using an on-site binding model.
4.4.6 Determination of pH-dependence
pH rate profiles were generated to measure the pH-dependence of TcAANAT0
with regards to acetyl CoA binding. Kinetic constants were measured at 0.25 pH
increments from pH 5.75 to pH 7.0 and 0.5 pH increments from pH 7.0 to pH 9.5 using
the following buffers: MES (pH 5.75 – 6.75), TRIS (pH 7.0 – 8.5) and CHES (pH 9.0 – pH
10.0). The data were fit using Visual Enzymics 2010 (IGOR Pro 6.34 A) Equation 4.11 for
a monobasic system with a slope of -2 indicating two unresolvable hydrogen ion
dissociation constants, and Equation 4.12 and Equation 4.13 for a dibasic system with an
acidic leg slope of -1 and -2 respectively. Here, y represents the kinetic constant
measured, either KM, kcat, or kcat/KM, C represents the maximum value for the kinetic
constant, H represents the hydrogen ion concentration, and Ka, K1 and K2 represent the
hydrogen ion dissociation constants. All fits were subjected to Levenberg-Marquardt
optimization to determine optimal fit.
Equation 4.11
𝑦=

𝐶
(𝐾 )2
(1 + 𝑎2 )
𝐻

Equation 4.12
𝑦=

𝐶
𝐻 𝐾
(1 + + 2 )
𝐾1 𝐻
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Equation 4.13
𝑦=

𝐶
𝐻 𝐾
𝐾𝐾
1 + + 2 + 1 22
𝐾1 𝐻
𝐻

4.4.7 Product characterization
Mass spectrometry was used to demonstrate that the kinetic activity recorded was
due to the formation of the acylamine product, and not simply due to hydrolysis of the
acyl-CoAs. The product was first generated by incubating 100 μg of TcAANAT0 with 3.5
mM tryptamine, 0.3 mM acetyl-CoA, and 300 mM Tris, pH 8.0 at 30°C for 10 minutes.
The enzyme was filtered out using a Millipore 10 kDa spin column and the remaining
solution containing the enzymatic product was diluted 500-fold. 20 μL was injected into a
Phenomenex Kinetex 2.6 μm C18 100 Å (50 mm × 2.1 mm) reverse phase column coupled
to an Agilent 6540 liquid chromatography/quadrupole time-of-flight mass spectrometry
(LC/QTOF-MS) in positive ion mode as described previously by Dempsey et al.30 A
commercial standard of N-acetyltryptamine was also run following the same method. The
retention times and high-resolution mass-to-charge ratios of the enzyme product and the
commercial standard were then compared to validate the catalytic product of the enzyme.
4.4.8 TcAANAT0 mutagenesis
To investigate the importance of individual residues in substrate binding and
catalysis, alanine scanning was performed on several residues which have classically
shown to be important in AANAT activity or are shown via crystal structure to be of
interest. The mutants made were: E25A, E25D, R134A, and F166A. Primers for these
mutants were designed using the Agilent QuikChange Primer Design tool, and the
mutants were synthesized using an Agilent QuikChange Lightning kit following the
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recommended procedure. Following transformation, all mutant DNA was sequenced to
confirm successful mutation. The mutant enzymes were cultured, purified and kinetically
analyzed following the same procedures as described above.
4.4.9 TcAANAT0 crystallization
Crystal screening was performed using an Art Robbins Instruments Phoenix Liquid
Handling robot and several commercially available screens from Qiagen. Hits identified
from screening were scaled up. TcAANAT0 was crystallized in 200 mM sodium citrate pH
5.5, and 20% PEG 3000, at 20°C using hanging drops in a 1:1:1 ratio
(protein:buffer:acetyl-CoA). Single crystals formed after 3-4 days and grew to full size in
6-7 days. The crystals were harvested and cryo-cooled using a solution of the
crystallization buffer with 20% glycerol and 10 mM acetyl-CoA added.
4.4.10 X-ray data collection and refinement
Data were collected using the 19-BM beamline of the Structural Biology Center
(SBC) at the Advanced Photon Source, Argonne, Illinois. Data was processed using
iMosflm, and the CCP4 suite was used to refine the data. Coot was used to build and
refine the complete model.57-59 PyMol was used to generate all protein structure figures.60
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CHAPTER FIVE:
Bm-iAANAT3: EXPRESSION AND CHARACTERIZATION OF A NOVEL
ARYLALKYLAMINE N-ACYLTRANSFERASE FROM BOMBYX MORI

Note to Reader: Portions of this chapter has been previously published in Archives of
Biochemistry and Biophysics, 2019, 661, 107-116 and has been reproduced as permitted
by Elsevier (See Appendix A).
5.1

Introduction
N-Acetylamides, CH3-CO-NH-R, have been isolated and characterized from a host

of vertebrates and invertebrates and are usually produced in vivo by a reaction between
acetyl-CoA, CoA-S-CO-CH3, and the corresponding amine, R-NH2.1–5 The enzymes
catalyzing amine N-acetylation are the arylalkylamine N-acetyltransferases (AANATs,
also known as arylalkylamine N-acyltransferases)6,7 which are members of the Gcn5related N-acetyltransferase enzyme superfamily.8–10 In insects, the iAANATs (iAANATs =
insect AANATs) produce N-acetylserotonin, an intermediate in melatonin biosynthesis,
and are also thought to function in controlling melanism,11,12 the inactivation of biogenic
amines,13,14 the sclerotization of the insect cuticle,14,15 and photoperiodism.7 Our interest
in the AANATs is derived from our work on the biosynthesis of the fatty acid amides,16,17
a family of cell signaling lipids.18 We and others have found that AANAT-like (AANATL)
enzymes will catalyze the formation of fatty acid amides from fatty acyl-CoA thioesters
and the corresponding amines.17,19–21 Database searches of insect genomes indicate that
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a number of iAANATs and iAANATLs could be expressed in a variety of insects.7,14,22
Thus, insects should serve as model organisms to better understand the possible role
played by the iAANATs and iAANATLs in the biosynthesis of N-acetyl- and Nacylarylalkylamides and to further define the biological function of these molecules. Much
remains unknown about the cellular function of the long-chain N-acylarylalkylamides and
other fatty acid amides.23
Herein, we report on the over-expression in E. coli, purification, and
characterization of recombinant Bm-iAANAT3, a third iAANAT from B. mori. B. mori
express two other iAANATs, Bm-iAANAT and Bm-iAANAT2.24,25 Our work on BmiAANAT3 contributes to an understanding of N-acyltransferase chemistry and will foster
the development of inhibitors targeted against insect N-acyltransferases, due to their
emergence as intriguing targets for insecticide design.26–28 In addition, we plan to extend
our mechanistic work on the AANATs to focus on structural elucidation by NMR and Xray crystallography. The other iAANATs we have over-expressed have thwarted such
experiments because these enzymes precipitate at high protein concentrations.20,21,29–32
Bm-iAANAT3 does not precipitate at high protein concentration enabling structural
studies of this enzyme by NMR.33,34
5.2

Results and Discussion

5.2.1 Cloning, expression, and purification of Bm-iAANAT3
Bm-iAANAT3 from Bombyx mori was successfully cloned, expressed, and purified
from E. coli using a codon-optimized gene, yielding 10.9 mg of Bm-iAANAT3 purified
protein per liter of culture. Purity was ≥95% as assessed by SDS-PAGE and the molecular
weight of the protein was in good agreement with its mass, 23.9 kDa for Bm-iAANAT3.
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Bm-iAANAT3 is a previously uncharacterized enzyme, and shares 32%, 24%, and 30%
sequence identity with Bm-iAANAT, Bm-iAANAT2, and Dm-AANATA, respectively
(Figure 5.1). It shares slightly less identity with the mammalian AANATs from human and
sheep, at 21% and 17% identity, respectively. These data provide additional evidence
that AANATs typically share poor sequence homology when compared against each

Figure 5.1: Homology overlays of iAANAT enzymes from Bombyx mori and Drosophila
melanogaster. The sequence data used in creating this figure are: D. melanogaster
AANATA (Dm-AANATA, accession number is NP_523839), B. mori iAANAT (BmiAANAT, accession number is NP_001073122.1), B. mori iAANAT2 (Bm-iAANAT2,
accession number is XP_004928436.2), and B. mori iAANAT3 (Bm-iAANAT3, accession
number is NP_001177771.1).
other, even between enzymes from organisms of the same phylum and class.9

5.2.2 Identification of amine and acyl-CoA substrates for Bm-iAANAT3
We have developed a screening strategy employing different pools of various
amine substrates (arylalkylamines, polyamines, aminoglycosides, ethanolamine,
histamine, and amino acids; (Table 5.1) that enables the rapid identification of substrates
for any putative N-acyltransferase. We have successfully utilized this strategy to identify
substrates for N-acyltransferases from Drosophila melanogaster.29–32
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Table 5.1: Pooled amine substrates for the initial screening assay
Pool

Concentration
of Each Amine
(mM)

1
2
3
4

60
60
60
20

5
6
7

20
60
20

Amino Donors
Lysine, Threonine, Glycine, Histamine, and Dopamine
Alanine, Arginine, Histidine, Tyramine, and Norepinephrine
Serine, Proline, Methionine, Serotonin, and Tryptamine
Glutamate, Asparagine, Valine, Ethanolamine, and
Octopamine
Aspartate, Isoleucine, Tryptophan, and Glutamine
Leucine, Phenylalanine, γ-Aminobutyric acid, and Taurine
Spermidine, Agmatine, Cadaverine, Putrescine, and
β-Alanine

In applying this strategy to identify amine substrates for Bm-iAANAT3, a relatively
high concentration of each amine (20 mM or 60 mM, Table 5.1) was included in the pool
because the KM value for glycine is reported at 6 mM for some of the glycine Nacyltransferases.35–37 Pools of acyl-CoA substrates were not constructed because of the
reports of long-chain acyl-CoAs acting as AANAT inhibitors;29,37,38 therefore, we
individually cross-screened amine pools against archetypal short and long-chain acylCoA thioesters, acetyl-CoA and oleoyl-CoA, because both have been reported as
substrates for other GNAT family acyltransferases.20,21 For Bm-iAANAT3, we found no
significant velocities with oleoyl-CoA above the low enzyme-independent, background
rate of oleoyl-CoA hydrolysis, suggesting that this enzyme does not catalyze the
formation of long-chain N-acylamides. Employing acetyl-CoA as substrate, a broad range
of amines were substrates exhibiting high rates of catalysis far above our background
threshold rate of 0.1 μmoles/min/mg. Six arylalkylamines (tryptamine, tyramine,
dopamine, octopamine, serotonin, and norepinephrine) and histamine were identified as
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substrates from the four amine pools that yielded positive results. Ranking the amine
substrates from the highest to the lowest kcat/KM values is as follows: tryptamine, tyramine,
dopamine, octopamine, serotonin, norepinephrine, and histamine (Table 5.2).
Table 5.2: Kinetic Constants for the Amine Substrates for Bm-iAANAT3a
Amine
Tryptamine
Tyramine
Dopamine
Octopamine
Serotonin
Norepinephrine
Histamine

KM
(μM)
97 ± 8.8
63 ± 6.7
330 ± 23
18 ± 0.8
1100 ± 63
140 ± 8.6
1700 ± 98

kcat
(s-1)
60 ± 1.2
27 ± 0.6
55 ± 1.1
2.2 ± 0.02
59 ± 1.0
5.3 ± 0.07
33 ± 0.68

kcat/KM
(M-1 s-1)
(6.2 ± 0.6) × 105
(4.3 ± 0.5) × 105
(1.6 ± 0.1) × 105
(1.2 ± 0.05) × 105
(5.2 ± 0.3) × 104
(3.7 ± 0.2) × 104
(1.9 ± 0.1) × 104

Relative
kcat/KM
33
23
8.4
6.3
2.7
1.9
1.0

The kcat/KM value for the best amine substrate, tryptamine = (6.2 ± 0.6) × 105 M-1
s-1, is ~30-fold higher than the value for the worst amine substrate, histamine = (1.9 ± 0.1)
× 104 M-1 s-1. Octopamine displayed the lowest KM value of 18 ± 1 µM, while histamine
displayed the highest KM of 1.7 ± 0.1 mM. None of the polyamines, aminoglycosides, or
amino acids we tested served as substrates for Bm-iAANAT3. Interestingly, acetyl-CoA
displayed the highest KM value of the acyl-CoA substrates,90 ± 4 µM. The other four acylCoA substrates, buytryl-CoA, hexanoyl-CoA, octanoyl-CoA, and decanoyl-CoA exhibited
nearly identical KM values of 10 to 14 µM (Table 5.3). As we have observed with other
insect AANATs,20,29–32 the (kcat/KM)acyl-CoA values decreased as the length of the acyl chain
increased for the acyl-CoA substrates: the (kcat/KM)acetyl-CoA is 170-fold higher than the
(kcat/KM)decanocyl-CoA. Decanoyl-CoA was the acyl-CoA substrate with the longest acyl-chain
that showed rates of CoA-SH formation that were significantly above the background rate
of enzyme-independent acyl-CoA hydrolysis. In addition, we found that malonyl-CoA is a
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substrate for Bm-iAANAT3 with a (kcat/KM)malonyl-CoA that is ~6-fold lower than the
(kcat/KM)decanocyl-CoA.
Table 5.3: Kinetic constants for the CoA thioester substrates (R-CO-S-CoA) for BmiAANAT3. Measurements were made at one, fixed initial concentration of tryptamine.
Reactions were run at 22°C in 300 mM Tris pH 8.0, 150 µM DTNB, 8.0 mM tryptamine,
and the acyl-CoA concentration was varied in the range 0.3 to 3.0 × KM
Acyl-CoA

R

KM
(μM)

kcat
(s-1)

kcat/KM
(M-1 s-1)

Relative
kcat/KM

Acetyl
Malonyl
Butyryl
Hexanoyl
Octanoyl
Decanoyl

CH3HOOC-CH2CH3(CH2)2CH3(CH2)4CH3(CH2)6CH3(CH2)8-

90  3.6
1900  300
14  0.8
13 ± 0.5
10 ± 1.0
12 ± 5.5

64  0.7
13  1.5
4.0  0.04
1.3 ± 0.01
0.36 ± 0.005
0.05 ± 0.004

(7.1  0.3) × 105
(7.0  1.3) × 103
(2.9 ± 0.2) × 105
(9.5 ± 0.4) × 104
(3.4  0.3) × 104
(4.2  1.9) × 104

170
0.17
70
23
8.1
1.0

To the best of our knowledge, this is the first report of malonyl-CoA serving as a
substrate for a GNAT enzyme. N-Succinylation, however, has been demonstrated in the
detoxification of mammalian xenobiotics,39,40 N-succinyl conjugates of octopomine,
serotonin, dopamine, and tyramine have been identified in C. elegans,41 Nsuccinylserotonin (bufobutanoic acid) is found in the venom of various toad species (the
traditional Chinese medicine, Ch’an Su).42 Crystallographic results also identified
succinyl-CoA bound in two GNAT enzymes in addition to the kinetic activity noted for
succinyl-CoA with TcAANAT0, noted in chapter 4.43,44 Our data showing that malonylCoA is a Bm-iAANAT3 substrate in combination with these other works hints that a panel
of N-malonylated and N-succinoylated amines may exist in both vertebrates and
invertebrates.
Our work on Bm-iAANAT3 follows earlier studies of two other iAANATs from B.
mori, Bm-iAANAT and Bm-iAANAT2.24,25 One of these, Bm-iAANAT, exhibited a wide
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expression pattern and accepted a diverse set of amines as substrates for Nacetylation.24 The combination of its broad tissue distribution and amine substrate
promiscuity led to the suggestion that Bm-iAANAT is the major enzyme of monoamine
catabolism in B. mori.24 The N-acetylation of dopamine is of particular significance in
monoamine catabolism. The production of N-acetyldopamine is a reaction critical to
sclerotization of the cuticle in insects.15 Dopamine is required for the formation of the
brown pigment, dopamine melanin, while N-acetyldopamine is the precursor for a
colorless pigment.45 In fact, B. mori defective in dopamine biosynthesis have a colorless
and improperly formed cuticle.46 The N-acetylation of serotonin is one of the reactions in
the conversion of tryptophan to melatonin.2,6 Since Bm-iAANAT catalyzes the acetylation
of both serotonin and dopamine, the enzyme is likely involved in melatonin and dopamine
melanin production in B. mori. Bm-iAANAT mutants exhibit higher than normal levels of
dopamine and widespread black pigmentation in the larvae and adult moths.11,46 Later, a
second B. mori iAANAT was discovered and characterized, Bm-iAANAT2.25 Transgenic
flies suppressing Bm-iAANAT2 expression exhibited elevated dopamine levels and
melanin deposition in the head and integument. These results suggest that BmiAANATL2 contributes to the regulation of melanism in B. mori.
Our substrate specificity studies of Bm-iAANAT3 show that this enzyme is a
“versatile generalist” capable of acylating a broad range of amines, with a preference for
acetyl-CoA as a co-substrate. All amines included in Table 5.2, apart from tryptamine,
have been identified in B. mori;47–51 thus, it is possible that Bm-iAANAT3 does catalyze
their acetylation in vivo. Information regarding the cellular concentration of the amines we
have identified as Bm-iAANAT3 substrates is limited. The hemolymph concentrations of
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dopamine, tyramine, and serotonin from the fourth instar, fifth instar, and pupa stages are
low, <10 μM,47 but it is not clear how these concentrations relate to their respective
intracellular concentrations. There are two reports of the brain concentrations of biogenic
amines in B. mori, all reported as pg/brain.47,48 If the volume of a B. mori brain is ~1 μL,
the highest concentration of dopamine and serotonin would be ~0.8 mM. These estimated
intracellular concentrations for dopamine and serotonin are comparable to the KM values
we determined for these amines, KM for dopamine = 0.33 mM and KM for serotonin = 1.1
mM (Table 5.2). Thus, Bm-iAANAT3 could have a role in the acetylation of dopamine and
serotonin in vivo; therefore, functioning in sclerotization, pigmentation, and melatonin
production.
5.2.3 Kinetic mechanism
Two different experimental approaches were used to deduce the kinetic
mechanism of Bm-iAANAT3. One set of experiments was to vary one substrate, acetylCoA or tryptamine, while holding the other substrate at a fixed initial concentration. Our
initial velocity data were subjected to global non-linear regression analysis, to differentiate
between several bi-bi kinetic mechanisms.52 The data fit equally well to Equation 3 for a
steady-state ordered kinetic mechanism and Equation 4 for a ping-pong mechanism; Chisquared values for the fits to equations 3 and 4 were the same within experimental error.
An equilibrium ordered kinetic mechanism would yield one plot of 1/v vs. 1/[substrate] that
intersect on the 1/v-axis, clearly inconsistent with the data shown in Figure 5.2.
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Figure 5.2: Bm-iAANAT3 double-reciprocal analysis of initial velocities for acetylCoA and tryptamine, fit to equation 3 in a global non-linear regression analysis. (A)
Velocities measured at fixed concentrations of tryptamine: 500 μM (), 250 μM (),
120 μM (◆), 60 μM () and 40 μM (). (B) Velocities measured at fixed
concentrations of acetyl-CoA: 200 μM (), 90 μM (), 40 μM (◆), 25 μM () and
15 μM ().
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A pattern of parallel lines for the plot of 1/v vs. 1/[substrate] at fixed concentrations
of the second substrate is often indicative of a ping-pong kinetic mechanism; however, a
steady-state ordered kinetic mechanism can yield a parallel pattern if the KM for substrate
A is greater than the dissociation constant for substrate A.52 This is exactly what we found
for acetyl-CoA, KM = 90 μM and Kd = 0.7 μM.34
Next, a set of dead-end inhibition studies were performed to provide additional
support for an ordered kinetic mechanism. Oleoyl-CoA and tyrosol were used as deadend inhibitors against acetyl-CoA and tryptamine, respectively. Neither analog exhibited
a rate of reaction above the baseline rate of hydrolysis, and both have been previously
utilized as dead-end inhibitors in studies of the D. melanogaster AANATs and mammalian
serotonin N-acetyltransferase.29,31,32,38 Oleoyl-CoA was competitive vs. acetyl-CoA
(Figure 5.3A) and noncompetitive vs. tryptamine (Figure 5.3B) with a Ki,s value of 220 ±
20 nM and Ki,s = Ki,i values of 790 ± 30 nM, respectively. Tyrosol was uncompetitive vs.
acetyl-CoA (Figure 5.3C) and competitive vs. tryptamine (Figure 5.3D), with a Ki,i value of
230 ± 10 μM and a Ki,s value of 90 ± 10 μM, respectively. Furthermore, these data indicate
that enzymatic generation of N-acetyltryptamine from acetyl-CoA and tyramine as
catalyzed by Bm-iAANAT3, most likely, occurs via an ordered sequential mechanism with
acetyl-CoA binding first followed by the binding of tryptamine to yield the catalytically
competent Bm-iAANAT3•acetyl-CoA•tryptamine ternary complex. An ordered sequential
kinetic mechanism has been attributed to several D. melanogaster AANATs and GNAT
enzymes.29–32,53–56
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Figure 5.3: Dead-end inhibition plots for Bm-iAANAT3. (A) Velocities measured at a fixed
concentration of tryptamine (100 μM) with varied concentrations of acetyl-CoA (10 μM,
25 μM, 50 μM, and 100 μM), at varied concentrations of the inhibitor, oleoyl-CoA: 0 nM
(⚫), 250 nM (), and 500 nM (); Ki = 220 ± 20 nM (B) Velocities measured at a fixed
concentration of acetyl-CoA (100 µM) with varied concentrations of tryptamine (50 μM,
100 μM, 150 μM, and 300 μM), at varied concentrations of the inhibitor, oleoyl-CoA: 0 nM
(⚫), 250 nM (), and 500 nM (), Ki = 790 ± 30 nM (C) Velocities measured at a fixed
concentration of tryptamine (100 µM) with varied concentrations of acetyl-CoA (10 μM,
25 μM, 50 μM, and 100 μM), at varied concentrations of the inhibitor, tyrosol: 0 μM (⚫),
150 μM (), and 300 μM (); Ki = 230 ± 10 μM (D) Velocities measured at a fixed
concentration of acetyl-CoA (100 M) with varied concentrations of tryptamine (50 μM,
100 μM, 150 μM, and 300 μM), at varied concentrations of the inhibitor, tyrosol: 0 μM (⚫),
150 μM (), and 300 μM (); Ki = 90 ± 10 μM
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Product inhibition is one method useful in defining the order of product release. NAcetyltryptamine produced competitive and noncompetitive inhibition plots against acetylCoA and tryptamine, respectively (Figure 5.4). These data are most consistent with an
ordered sequential product release, with CoA-SH being released first followed by release
of the acetylated product, N-acetyltryptamine. This is similar to the order of product
release reported for N-myristoyltransferase.56 We found that order of product release for
D. melanogaster agmatine N-acetyltransferase (DmAgmNAT) was the N-acetylated
product first followed by CoA-SH,32 similar to that reported for human histone
acetyltransferase (HAT) and Enterococcus faecium aminoglycoside acetyltransferase
(AAC((6’)-I).53,54 The product inhibition patterns for Bm-iAANAT3 (Figure 5.4) differed
from those reported for DmAgmNAT, HAT, and AAC((6’)-I.

Figure 5.4 Product inhibition of Bm-iAANAT3 by N-acetyltryptamine. (Left) Initial
velocities measured at a fixed concentration of tryptamine (100 μM), varying the
concentrations of acetyl CoA, and varying the concentration of the inhibitor, Nacetyltryptamine: 0 mM, 1.0 mM, 5.0 mM; KI,i = 640 ± 60 mM. (Right) Initial velocities
measured at a fixed concentration of acetyl CoA (100 μM), varying the concentrations
of tryptamine, and varying the concentration of the inhibitor, N-acetyltryptamine: 0 mM,
1.0 mM, 5.0 mM. KI,s = 4.2 ± 0.2 mM.
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A steady-state ordered bi-bi kinetic mechanism with acetyl-CoA binding first and
N-acetyltryptamine being released last (Figure 5.6) is consistent with the binding data of
Aboalroub et al..34 Direct binding measurements by ITC and/or NMR showed that acetylCoA and N-acetyltryptamine bound to Bm-iAANAT3 with Kd values of 0.7 ± 0.03 μM and
12 ± 3 μM. The binding of N-acetyltryptamine was eliminated by the addition of acetylCoA and was not affected by the addition of CoA-SH. The binding of tryptophol, the nonsubstrate alchohol analog of tryptamine, was significantly enhanced by the presence of
acetyl-CoA, the Kd value decreasing from 230 ± 12 μM to 50 ± 2 μM. Lastly, CoA-SH
binds to Bm-iAANAT3 with low affinity, a Kd of 30 ± 1 μM. Relatively weak binding of
tryptamine, Kd = 220 ± 8 μM, and CoA-SH to free Bm-iAANAT indicates that kinetic
mechanism is actually random bi-bi with a strong preference for acetyl-CoA binding first
and N-acetyltryptamine being released last.
5.2.4 pH dependence of the kinetic constants and identification of a catalytic base
We determined the pH-dependence of the kinetic constants for acetyl-CoA to aid
in our identification of amino acids important in catalysis and substrate binding in BmiAANAT3. Both the kcat, and (kcat/KM)acetyl-CoA pH-rate profiles exhibited a pH-dependent
rise from pH 6.5 to 8.0 following by a pH-independent plateau above pH 8. These data
are best fit to equation 8 with a pKa value of 7.3 ± 0.1 for both profiles (Figure 5.5), pointing
towards a catalytically important base with a pKa of 7.3. This pKa value likely corresponds
to the general base deprotonating the primary amine of tryptamine; alternatively, it could
be attributed to the zwitterionic tetrahedral intermediate that is produced after the
nucleophilic attack of the acetyl-CoA thioester by tryptamine. This set of experiments did
not uncover a second, higher pKa value; this additional pKa (~8.5 – 10.0) would
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correspond to a general acid in catalysis, routinely observed for NAT enzymes.9,31,57 We
hypothesize that Bm-iAANAT3 either lacks a general acid in catalysis, or the general acid
has a pKa value > 9.5, a number too high for us to ascertain due to limitations of acetyl-

(

CoA hydrolysis and/or DTNB instability at elevated pH ranges.

Figure 5.5: pH rate profiles for Bm-iAANAT3. (Top) Log(kcat)versus pH for acetyl-CoA.
(Bottom) Log(kcat/KM) versus pH for acetyl-CoA.
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5.2.5 Identification of a catalytic base and a potential chemical mechanism for
catalysis
Alignment of the amino acid sequence of Bm-iAANAT3 to those for other insect
AANATs shows that Glu-27 of Bm-iAANAT3 corresponds to Glu-47 of AANATA from D.
melanogaster (Figure 5.1). Dempsey et al. have shown that Glu-47 is likely the catalytic
base in that enzyme.29 Thus, we mutated Glu-27 to Ala in Bm-iAANAT3. The E27A
mutant enzyme was cultured, purified, and characterized in the same manner as the wildtype Bm-iAANAT3. The kinetic constants we measured for the E27A mutant were:
KM,acetyl-CoA = 20 ± 2.2 μM, kcat,acetyl-CoA = 4.0 ± 0.09 × 10-2 s-1, KM,tryptamine = 9400 ± 990 μM,
and kcat,tryptamine = 8.0 ± 0.3 × 10-2 s-1. Thus, the E27A mutant retained only 0.06% to
0.13% of the wild-type kcat while exhibiting 100-fold increase in the KM for tryptamine. The
significant decline in catalytic activity as compared to wild-type Bm-iAANAT3, in addition
to the large perturbation in the KM,tryptamine, suggests that this residue functions as a
general base in catalysis, as well as playing a role in substrate binding. Glu-27 likely
represents the pKa value of 7.3 observed in the pH-rate profile (Figure 5.5). The ~1000fold decrease in kcat value for the E27A mutant falls in the range of values measured for
general base mutants of other N-acyltransferases in GCN5 family (Table 5.4). A larger
kcat effect was measured after the mutation of the catalytic base in mandelate racemase,
a ~10,000-fold decrease in the kcat of the D270N mutant.58
Given the results for the D270N mutant in mandelate racemase, the general base
mutants of Bm-iAANAT3 and the other N-acyltransferases in Table 5.4 have surprisingly
high kcat values. Most likely, this results from another chemical species serving as a base
in catalysis. Perhaps, an active site water molecule of the “proton-wire” found in the active
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site of this family of enzymes or another active site amino acid can serve as the “backup” during catalysis in the absence of the preferred catalytic base.8 Partial rescues of the
general base mutants of Dm-AANATL7,31 DmAgmNAT,32 and yeast-HAT at high pH point
towards an active site hydroxide serving as the catalytic base.59 In addition, Scheibner et
al. argue that His-120 is the catalytic base in serotonin N-acetyltransferase and that His122 is catalytically redundant, serving as the base in the H120A mutant.57 While the kcat
is only slightly depressed for the individual H120A and H122A mutants ~3-5-fold, the kcat
for the double mutant, H120A/H122A, is significantly lower, decreased ~280-fold (Table
5.4).
Table 5.4: Ratio of (kcat,wildtype)/(kcat,mutant) for general base mutant enzymes. Dm =
Drosophila melanogaster and Bm = Bombyx mori. Glu-29 is most likely not the catalytic
base for Dm-AANATL2.
Enzymea
DmAgmNAT
Bm-iAANAT3
Yeast-HAT

Mutation
E34A
E27A
E173Q

Dm-AANATL7
Dm-AANATA
Ovine-SNAT

E26A
E47A
H120A
H122A
H120A/H122A
E29A

Dm-AANATL2b

(kcat,wildtype)/(kcat,mutant)
~2100
~1000
~320 at pH 7.5
~6 at pH 9.5
~22
~13-170
~5
~3
~280
~1.0

Ref.
32
This work
58
31
29,60
56

30

When taken together, our data strongly supports the mechanism depicted in Figure
5.6. The double-reciprocal plots and dead-end inhibition analysis indicate an ordered
sequential mechanism: acetyl-CoA binds first, followed by tryptamine, leading to the BmiAANAT3•acetyl-CoA•tryptamine ternary complex before catalysis occurs. After the
binding of both substrates into the active site, the positively charged amine moiety of
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tryptamine is deprotonated by Glu-27 (the catalytic base) through an ordered set of water
molecules. The amine deprotonation step is followed by nucleophilic attack of the
deprotonated amine at the carbonyl of the acetyl-CoA thioester to generate a tetrahedral
intermediate. The zwitterionic tetrahedral intermediate collapses as the coenzyme A
thiolate is protonated by the positively charged amine of the intermediate to yield the two
products: CoA-SH and N-acetyltryptamine. Our product inhibition studies show that
product release is ordered with CoA-SH exiting first, followed by N-acetyltryptamine.

Figure 5.6: Proposed mechanism for the Bm-iAANAT3-catalyzed N-acetylation of
tryptamine.
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5.3

Conclusion
We have cloned, over-expressed in E. coli, and characterized a previously

unknown iAANAT from B. mori, Bm-iAANAT3. The kinetic mechanism for Bm-iAANAT3
with acetyl-CoA and tryptamine is bi-bi steady-state ordered with acetyl-CoA binding first
and N-acetyltryptamine released last. Studies of the chemical mechanism suggest that
Glu-27-mediated deprotonation of the amine substrate facilitates nucleophilic attack of
the amine at the carbonyl of the acetyl-CoA thioester. Collapse of the resulting tetrahedral
intermediate immediately leads to product release, the N-acetylated amine likely leaving
first, followed by the CoA-SH by-product.
Substrate specificity data reveal that Bm-iAANAT3 prefers short-chain acyl-CoA
thioesters with acetyl-CoA as the best acyl-CoA substrate. While fatty acid amides have
been recently identified in B. mori,21 Bm-iAANAT3 is probably not involved in their
biosynthesis in vivo. Bm-iAANAT3 accepts a variety of amines as substrates pointing
towards a cellular role for this enzyme in amine inactivation and/or excretion. In addition,
Bm-iAANAT3 may have role in sclerotization, melanism, and melatonin biosynthesis by
catalyzing dopamine and serotonin acetylation. Our identification of malonyl-CoA as a
Bm-iAANAT3 substrate suggests that a series of biologically-occurring N-malonylated
and N-succinoylated amines await discovery and characterization; a suggestion
consistent with the identification of N-succinoylated amines in C. elegans.41 Why B. mori
would express three iAANATs, Bm-iAANAT, Bm-iAANAT2, and Bm-iAANAT3, with
potentially overlapping cellular functions is unknown. Future Bm-iAANAT3 knockdownexperiments in B. mori are planned to address the question of its cellular function.
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5.4

Experimental procedures

5.4.1 Materials
Unless otherwise noted, all reagents were of the highest quality available from
commercial sources. Purchasing details are noted in Chapter 4, Section 4.3.1.
5.4.2 Cloning of Bm-iAANAT3
Bm-iAANAT3 (Accession no. NM_001190842.1) was cloned, overexpressed and
purified following the procedure described in Chapter 3, Section 3.4.1.
5.4.3 Substrate identification for Bm-iAANAT3
An activity-based screening protocol was used to identify substrates for BmiAANAT3. First, the enzyme was evaluated using acetyl-CoA (representative of a shortchain CoA) or oleoyl-CoA (representative of a long-chain CoA) separately, with different
groups of pooled amines. The groups of amines are listed in Table 5.1. Each assay
consisted of 300 mM Tris pH 8.0, 150 μM DTNB (Ellman’s reagent, 5,5’-dithiobis(2-nitrobenzoic acid), 500 μM acyl-CoA, and individual amines at 20 mM or 60 mM. Initial
velocities were determined by measuring the release of CoA at 412 nm using Ellman’s
reagent (ε412 = 13,600 M-1 cm-1) and were calculated after the background rate of CoA
thioester hydrolysis was subtracted from the observed velocity. Any amine pool that
displayed a background corrected rate ≥0.1 μmoles/min/mg (≥0.04 M-1 s-1) in combination
with acetyl-CoA or oleoyl-CoA was further evaluated to identify the specific Bm-iAANAT3
substrate(s) contained within that pool. Each amine within that group was individually
interrogated at a relatively high concentration in the presence of acetyl-CoA or oleoylCoA to determine if the amine was truly a substrate for Bm-iAANAT3. The assay
conditions were identical to that described for the screening protocol using the amine
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pools. Individual amines that displayed a background corrected rate of ≥0.1
μmoles/min/mg were included in our measurements for additional kinetic analysis.
5.4.4 Determination of the steady-state kinetic constants
Steady-state kinetic characterization of Bm-iAANAT3 was carried out using
Ellman’s reagent to measure the release of CoA under the following conditions: 300 mM
Tris pH 8.0, 150 μM DTNB, and varying concentrations of acyl-CoA and amine substrates
at 22°C.
To determine the kinetic constants for the acyl-CoA substrates, the initial
tryptamine concentration was 8.0 mM, while varying the concentration of the acyl-CoA
substrates. To determine the kinetic constants for the amine substrates, the initial acetylCoA concentration was 500 μM, while varying the amine.
The kinetic constants for the acyl-CoA and amine substrates for Bm-iAANAT3
were determined by fitting the resulting data to Equation 5.1 using SigmaPlot 12.0: vo
represents initial velocity, Vmax is the maximal velocity, KM is the Michaelis Menten
constant, and [S] is the concentration of the varied substrate. Note that the concentration
of the other substrate was fixed at relatively high (saturating) concentration. Assays were
performed in triplicate and the uncertainty for the kcat and kcat/KM values were calculated
using Equation 5.2, with σ as the standard error.

Equation 5.1
vo =

Vmax [S]
K M + [S]
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Equation 5.2
σy 2
x
x σx 2
σ ( ) = √( ) + ( )
y
y
x
y
5.4.5 Kinetic mechanism for Bm-iAANAT3
5.4.5.1

Double reciprocal analysis

To differentiate between sequential and classic ping-pong kinetic mechanisms,
double-reciprocal plots of the initial velocity data were generated for acetyl-CoA and
tryptamine in SigmaPlot 12.0. Non-linear regression analysis of initial rates and model
discrimination analyses were performed in WaveMetrics IGOR Pro 6.34A. Initial velocities
were determined by varying the concentration of one substrate, while holding the other
substrate at a fixed concentration. The two plots were generated by holding the
tryptamine concentration constant (40 μM, 60 μM, 120 μM, 250 μM, and 500 μM) and
varying the concentration of acetyl-CoA. Accordingly, the second plot held the
concentration of acetyl-CoA constant (15 μM, 25 μM, 40 μM, 90 μM, and 200 μM) and
varied the tryptamine concentration. The resulting initial velocity data was fit to Equation
5,3 for an ordered bi-bi mechanism and to Equation 5.4 for ping-pong mechanism, where
vo is the initial velocity, Vmax is the maximal velocity, [A] is the concentration of substrate
A, [B] is the concentration of substrate B, KIa is the dissociation constant for substrate A,
Kb is the Michaelis Menten constant for substrate B, and Ka is the Michaelis Menten
constant for substrate A. Kia, the dissociation constant for acetyl-CoA, was fixed at 0.7
μM, based on the direct measurement of acetyl-CoA binding to Bm-iAANAT3 by
isothermal calorimetry (ITC).34
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Equation 5.3
vo =

Vmax [A][B]
K Ia K b + K a [B] + K b [A] + [A][B]

Equation 5.4
Vmax [A][B]
K a [B] + K b [A] + [A][B]

5.4.5.2

Dead-end inhibition with oleoyl-CoA, tyrosol, and N-acetyltryptamine

To further define the kinetic mechanism of Bm-iAANAT3, we performed dead-end
and product inhibition analysis using oleoyl-CoA, tyrosol, and N-acetyltryptamine. The
initial velocities were generated by holding one substrate (either acetyl-CoA or
tryptamine) at a fixed concentration, varying the concentration of the other substrate, at
different fixed concentrations of each inhibitor. All assays were performed in triplicate,
and the resulting data was fit to Equation 5.5, Equation 5.6 and Equation 5.7 in SigmaPlot
12.0 for competitive, noncompetitive, and uncompetitive inhibition. Here, vo is the initial
velocity, Vmax is the maximal velocity, KM is the Michaelis Menten constant, [S] is the
substrate concentration, [I] is the inhibitor concentration, and KI,s is the dissociation
constant for the dissociation of I from the E•I complex, and KI,i is the dissociation constant
for the dissociation of I from the E•S•I complex.
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Equation 5.5
vo =

Vmax [S]
[I]
K M (1 +
+ [S]
K I,s )

Equation 5.6
vo =

Vmax [S]
[I]
[I]
K M (1 +
+ [S] (1 +
)
K I,s
K I,i )

Equation 5.7
vo =

Vmax [S]
K M + [S] (1 +

5.4.5.3

[I]
K I,i )

pH dependence of the steady-state kinetic constants

The pH dependence of the kinetic constants was determined for both tryptamine
and acetyl-CoA at intervals of 0.5 pH units ranging from pH 6.0 to 9.5. The buffers used
were the following: MES (pH 6.0 – 6.5), Tris (pH 7.0 – 9.0) and AmeP (pH 9.0 – 9.5). The
resulting kinetic data were fit to Equation 5.8 and Equation 5.9 in WaveMetrics IGOR Pro
6.34A to delineate the pKa values of measured ionizable groups. In both equations, c is
the pH-independent plateau.
Equation 5.8
log(k cat /K M ) = log[c/(1 + 10pKa−pH )]

Equation 5.9
log k cat = log[c/(1 + 10pKa−pH )]
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5.4.6 Cloning, expression, and purification of site-directed mutants
To further investigate the role of individual amino acids potentially involved in
substrate binding and catalysis, a pair of Bm-iAANAT3 mutants was produced: E27A and
S167A. The generation of both mutants was carried out using the overlap extension
method.61 Mutants were amplified with the PfuUltra High-Fidelity DNA polymerase with
the following PCR conditions: an initial denaturation step of 95°C for 2 minutes, followed
by 30 cycles of PCR amplification (95°C for 30 s, 58°C for 30 s, 72°C for 1 min), and a
final extension step of 72°C for 10 minutes. Primers were designed on the Agilent
QuickChange Primer Design tool and purchased from Eurofins MWG Operon. PCR
products were digested with NdeI and XhoI restriction enzymes and ligated into the
pET28a vector with DNA ligase acquired from New England Biolabs. Mutant enzymes
were expressed and purified in the same manner as wild type Bm-iAANAT3.
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CHAPTER SIX:
WHAT REMAINS TO BE UNEARTHED?
ACTIVE-SITE DISORDER HOLDS KEY TO LONG-CHAIN ACYLATION BY AANAT

6.1

Introduction
The transfer of an acyl group from an acyl-CoA donor to a hydroxyl, thiol,

phosphate or amine of some biologically relevant acceptor is of vital importance in nature
and is found in essentially every living organism. While it is correct to call all enzymes
that perform this function ‘acyltransferases’, historically, research has tended to focus on
acetylation. This is due to the widespread prominence of acetylation in metabolism, such
as in glycolysis,1 protein post-translational modification,2,3 gene transcription,4–6 and
circadian rhythm.7,8 Due to the significance of acetylation,9 the enzymes which govern its
catalysis are separated from other forms of acylation into their own class: the
acetyltransferases.
Indeed, the concept of acylation is primarily reserved for protein fatty acylation:10
the transfer of a fatty acyl group (upwards of eight carbons) such as myristate and
palmitate to an acceptor,11,12 usually to the N-terminal and N-epsilon positions of peptides
and proteins. Protein fatty acyltransferases have been shown to enhance membrane
binding as well as mediate protein-protein interactions.13–15 However, the discovery of Narachidonylethanolamine (anandamide),16 the endogenous ligand for the cannabinoid
receptor in 1992 introduced the field of fatty acid amide research, focused on elucidating
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the role of fatty acid amides in cell signaling. The panel of known fatty acid amides quickly
grew to include not just the N-acyl amino acids synonymous with protein fatty acylation,
but also the N-acylethanolamines,17,18 N-acylarylalkylamides,19,20 and the primary fatty
acid amides.21 Indeed, several studies have demonstrated the presence of panels of
these long-chain compounds in mammals,22 Drosophila melanogaster,23 and Bombyx
mori.24
The biosynthetic pathways of many of these species remains largely unknown,25
however there are two primary pathways that have been suggested. These include a
condensation reaction between the corresponding fatty acid and amine substituents
catalysed by fatty acid amide hydrolase (FAAH),26 and the transfer of the fatty acyl group
from a CoA donor to an amine acceptor catalyzed by the corresponding Nacyltransferase.27 The former of these is unlikely, as it was found that several long-chain
N-acylserotonins are, in fact, inhibitors for FAAH.28 It was therefore hypothesized that a
family of N-acyltransferases exist which catalyze the biosynthetic pathway of these fatty
acid amides.
6.2

AANATs to fill the gap?
The Gcn5-related N-acetyltransferase (GNAT) superfamily holds some possible

candidates for fatty acid amide synthesis.29 This group of enzymes is perhaps most wellknown for the acetylation of specific lysine resides on histones,30 catalyzed by histone
acetyltransferase, an important regulator of gene transcription. In the context of fatty acid
amide synthesis however, attention has turned to one group of GNAT enzymes, known
as the arylalkylamine N-acetyltransferases (AANATs). In mammals, AANAT catalyzes the
N-acetylation of serotonin to form N-acetylserotonin.31,32 Subsequent methylation by
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acetylserotonin-O-methyltransferase forms melatonin, an important regulator of the
sleep-wake cycle.7,33,34
Just one AANAT has been discovered in mammals so far: serotonin Nacetyltransferase. However, it remains possible that another AANAT-like enzyme exists,
which catalyzes the formation of endogenous fatty acid amides. To determine the
possibility of this, more readily available model organisms were implemented; primarily
insects. While mammals contain a solitary identified AANAT, insects harbor numerous
discrete AANATs. For context, Drosophila melanogaster, the fruit fly, expresses eight
putative AANATs, while Aedes aegypti, the yellow-fever mosquito, expresses at least
thirteen.20,35 It seemed feasible that were an AANAT to exist in insects which is involved
in the biosynthesis of fatty acid amides, a similar enzyme likely exists in mammals.
The role of AANATs in insects is a much more indiscriminate one. They are
associated with the formation of N-acetyldopamine, an important aspect of cuticle
sclerotization in many insects.36 The distinct lack of monoamine oxidase (MAO) in insects
also imparts the function of bioactive amine inactivation upon AANATs.37–39 Numerous
labs, including our own, have contributed tirelessly to expressing and characterizing
AANATs from numerous different insects, both structurally and functionally. This list
includes the aforementioned D. melanogaster20,23,27,40–45 and A. aegypti,35,46,47 and
additionally Bombyx mori,24,48–52 Periplaneta americana,53–55 Acyrthosiphon pisum56 and
Tribolium castaneum.57 It was discovered that these AANATs universally utilized acetylCoA as a donor for traditionally a large panel of primary amines, not just arylalkylamines
such as tryptamines and catecholamines, but also polyamines such as spermidine and
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putrescine. In this context, a large percentage of AANATs studied function solely as Nacetyltransferases, rather than the putative fatty N-acyltransferases claimed to exist.
6.3

Long-chain acyltransferase activity in AANATs
Two exceptions were discovered however, namely D. melanogaster AANATL2

(DmAANATL2),58 and B. mori AANAT (Bm-iAANAT).24 While these enzymes were found
to function with acetyl-CoA, activity was also recorded for long-chain fatty acyl-CoAs. Both
enzymes were found to function with oleoyl-CoA and palmitoyl-CoA acting as acyl donor,
and additionally for Bm-iAANAT, arachidonyl-CoA, myristoyl-CoA, and lauroyl-CoA.
Table 6.1: Summary of kinetic data obtained for Bm-iAANAT and DmAANATL2 utilizing
acyl-CoAs of varying chain-length
Bm-iAANAT
Arachidonyl-CoA
Oleoyl-CoA
Palmitoyl-CoA
Myristoyl-CoA
Lauroyl-CoA
Acetyl-CoA
DmAANATL2
Oleoyl-CoA
Palmitoyl-CoA
Butyryl-CoA
Acetyl-CoA

kcat (s-1)
0.27 ± 0.02
0.42 ± 0.02
0.51 ± 0.01
0.66 ± 0.01
1.3 ± 0.12
0.12
kcat (s-1)
0.075 ± 0.003
0.16 ± 0.009
0.53 ± 0.011
1.3 ± 0.012

KM (μM)
1.2 ± 0.67
1.7 ± 0.51
1.1 ± 0.3
0.92 ± 0.20
0.97 ± 0.12
0.31
KM (μM)
3.6 ± 0.58
9.9 ± 1.6
15 ± 1.8
25 ± 1.8

kcat/KM (M-1s-1)
(2.4 ± 1.3) x 105
(2.4 ± 0.7) x 105
(4.9 ± 1.4) x 105
(7.2 ± 1.5) x 105
(1.4 ± 0.2) x 105
3.9 x 103
kcat/KM (M-1s-1)
(2.1 ± 0.09) x 104
(1.6 ± 0.09) x 104
(2.9 ± 0.06) x 105
(2.2 ± 0.02) x 105

These data suggest that an AANAT or AANAT-like enzyme is indeed capable of
synthesizing fatty acid amides, albeit at a very slow rate; recorded DmAANATL2 kcat for
oleoyl-CoA is approximately 17-fold lower than that recorded for acetyl-CoA. The
significantly decreased rate that comes with increasing acyl-chain length can be attributed
to the potency of these fatty acid amides.19 Simply put, they are not needed as abundantly
as their acetylated counterparts. It is interesting to note, however, that Bm-iAANAT is
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essentially non-discriminatory in its acyl-chain length preferences. While functioning
better with long-chain acyl-CoA donors, it shows relatively uniform activity from lauroyl(C12) to arachidonyl-CoA (C20). This is in contrast to DmAANATL2, which seems to
balance a plummeting kcat with increased affinity (decreasing KM). These balance out
quite comfortably in the measured specificity constants (kcat/KM) with a single order of
magnitude difference between activity recorded for short- and long-chain acyl CoAs.
To date, Bm-iAANAT and DmAANATL2 are the only AANATs that have been
identified that use long-chain acyl-CoAs as donor substrates. However, evidence for this
common ancestor is apparent across many characterized AANATs. Firstly, comparison
of kinetic constants and substrate specificity shows that the acyl-binding pocket of all
AANATs is fully capable of binding both short- and long-chain acyl CoAs. Long-chain
acyl-CoAs have commonly been shown to be potent inhibitors for AANAT, rudimentarily
demonstrating nanomolar KI values.49,59 Ferry et al. also demonstrated sub-micromolar
inhibition for acyl-CoAs C10 and above against human AANAT.60 Additionally, a steadily
decreasing KI/IC50 demonstrates that not only do fatty acyl-CoAs act as inhibitors, but it
appears that the longer the chain, the stronger the inhibition. This trend of proportionally
tighter binding is similar to that shown for DmAANATL2 KM values, which has also been
seen in several other insect AANATs, such as Tribolium castaneum AANAT discussed in
Chapter 3 and Chapter 4.
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Table 6.2: Summary of kinetic data obtained for TcAANAT0 and TcAANAT1b utilizing
acyl-CoAs of varying chain-length
TcAANAT0
Decanoyl-CoA
Butyryl-CoA
Acetyl-CoA
TcAANAT1b
Decanoyl-CoA
Butyryl-CoA
Acetyl-CoA

kcat (s-1)
0.8 ± 0.1
5.5 ± 0.1
29 ± 0.6
kcat (s-1)
3.4 ± 0.1
14 ± 0.5
52 ± 2.5

KM (μM)
0.9 ± 0.2
15 ± 1.8
25 ± 1.8
KM (μM)
6.7 ± 0.8
45 ± 4.9
65 ± 9.8

kcat/KM (M-1s-1)
(9.6 ± 2.2) x 105
(3.7±0.5) x 105
(1.2±0.1) x 106
kcat/KM (M-1s-1)
(5.1 ± 0.6) x 105
(3.1 ± 0.4) x 105
(8.0 ± 0.1) x 105

The implication of these trends is apparent with further comparison with a panel of
other AANATs studied, such as DmAANATA,43 DmAgmNAT,42 and Bm-iAANAT3.49
Rather than displaying similar trends to T. castaneum AANAT, these display either slight
preference for medium-chain acyl-CoA substrate binding, or no apparent preference.

Table 6.3: Summary of kinetic data obtained for DmAANATA, Bm-iAANATL3 and
DmAgmNAT utilizing acyl-CoAs of varying chain-length
DmAANATA
Decanoyl-CoA
Octanoyl-CoA
Hexanoyl-CoA
Butyryl-CoA
Acetyl-CoA
Bm-iAANAT3
Decanoyl-CoA
Octanoyl-CoA
Hexanoyl-CoA
Butyryl-CoA
Acetyl-CoA
DmAgmNAT
Decanoyl-CoA
Octanoyl-CoA
Hexanoyl-CoA
Butyryl-CoA
Acetyl-CoA

kcat (s-1)
0.04 ± 0.01
0.26 ± 0.01
1.6 ± 0.1
9.9 ± 0.4
16 ± 1
kcat (s-1)
0.05 ± 0.004
0.36 ± 0.005
1.3 ± 0.01
4.0 ± 0.04
64 ± 0.7
kcat (s-1)
0.16 ± 0.01
0.61 ± 0.02
1.1 ± 0.04
3.3 ± 0.1
23 ± 1

KM (μM)
220 ± 60
18 ± 3
23 ± 3
36 ± 2
39 ± 12
KM (μM)
12 ± 5.5
10 ± 1.0
13 ± 0.5
14 ± 0.8
90 ± 3.6
KM (μM)
70 ± 10
140 ± 10
110 ± 3
40 ± 6
100 ± 6
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kcat/KM (M-1s-1)
(1.7 ± 0.5) x 102
(1.4 ± 0.3) x 104
(6.8 ± 0.9) x 104
(2.8±0.2) x 105
(4.1±1.3) x 105
kcat/KM (M-1s-1)
(4.2 ± 1.9) x 104
(3.4 ± 0.3) x 104
(9.5 ± 0.4) x 104
(2.9±0.2) x 105
(7.1±0.3) x 105
kcat/KM (M-1s-1)
(2.2 ± 0.3) x 103
(4.4 ± 0.4) x 103
(9.7 ± 0.6) x 103
(8.0 ± 1) x 104
(2.2 ± 0.2) x 105

This indicates that rather than discrete AANAT families that can either long-chain
acylate or short-chain acylate, a single group of enzymes have evolved from a common
ancestor to accommodate both functions across a spectrum of specificity. Through
evolutionary stress, each insect has developed a panel of AANATs which stretches this
spectrum in the context of its biological requirements (Figure 6.1) In this sense, this family
should most accurately be called the arylalkylamine N-acyltransferases.

Long-chain acylation

Short-chain acylation

DmAANATA

Bm-iAANAT3

TcAANAT0/1

DmAgmNAT

Bm-iAANAT
DmAANATL2

Figure 6.1: Schematic demonstrating the inherent spectrum of acylation utilized by
various insect AANATs based off their obtained kinetic data. The further left the enzyme
is found, the less likely it is to perform long-chain acylation.

6.4

Phylogenetic and Structural insight into long-chain acylation
It may be assumed that the divergence between long- and short-chain acylators in

the AANAT family can be traced phylogenetically. Construction of a Maximum Likelihood
tree in MEGA7,62,63 however, displays little in the way of trends in support of clear genetic
divergence one way or another (Figure 6.2). While the low sample size means accurate
hereditary examination is a primary concern, another trait that many members of the
AANAT family is their strikingly low sequence homology; often <40% from AANAT to
AANAT.64 This lack of sequence identity means that no definitive motifs can be attributed
to long- or short-chain acylation.
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Figure 6.2: Phylogenetic tree built using the Maximum Likelihood method of AANATs
from Drosophila melanogaster (Dm), Aedes aegypti (Aa), Tribolium castaneum (Tc)
Periplaneta americana (Pa), Antheraea pernyi (Ap), Bombyx mori (Bm), Gallus gallus
(Gg), Homo sapiens (Hs), Callorhinchus milli (Cm), and Danio rerio (Dr). AANATs
known to favor long-chain acylation are boxed. Evolutionary analyses were conducted
in MEGA7. The percentage of trees in which the associated taxa clustered together is
shown next to the branches.
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However, through the use of homology modeling, we are able to make predictions
structurally as to why some AANATs can catalyze long-chain acylation, and some cannot.
A homology model for DmAANATL2 was built using the crystal structure of DmAANATA
as the template.61 The high structural homology synonymous with the GNAT superfamily
means that homology models are predicted to be very close to actual crystal structure
data. Comparison of the homology model of DmAANATL2 with DmAANATA
demonstrates, predictably, a relatively conserved structure. There are stark differences
however, in the organization of the amine binding pocket. The basic shape of AANAT
constitutes a cone, with the acyl-CoA donor stretching into the core of the enzyme, and
the acceptor entering from the other side. The differences between the amine binding
pockets are illustrated in Figure 6.3. An alignment of DmAANATA (blue) with
DmAANATL2 (red) shows that the opening for the amine, and thus, the active site, is
much more disordered in DmAANATL2 (disorder shown in orange) than in DmAANATA
(disorder shown in cyan).
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Figure 6.3: Overlay of crystal structure obtained for DmAANATA (3TE4 - blue) with
homology model of DmAANATL2 (red). Shown in cyan is one region of disorder in the
amine binding pocket of DmAANATA. Shown in orange is the much more pronounced
region of disorder of the pocket of DmAANATL2.

The motif stretching from residue 94 to 104 of DmAANATA, shown in cyan in
Figure 6.3 corresponds to the disordered region in DmAANATL2 stretching from residue
78 to 91. This cyan region ends in a short α-helix, a feature missing from DmAANATL2.
Every other region displayed in orange is completely ordered in DmAANATA and, all
together, this totals approximately 12% more disorder in DmAANATL2, all localized in the
amine binding pocket. The implications of this in relation to the ability to catalyze longchain acylation lies in the degrees of freedom offered by this disorder. A more dynamic
amine binding pocket means that even if the acyl-CoA chain extends into the amine
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pocket, the flexible nature of the pocket can more readily accommodate this and adjust
to facilitate binding of the amine.
6.5

Conclusion
The identification of several panels of long-chain fatty acid amides in many

different organisms and a distinct lack of understanding of many of their biosynthetic
pathways is an intriguing conundrum. Kinetic analysis has shown us that AANATs in
insects exist which can catalyze the reaction necessary. Through steric modification of
the active site, insects have developed a way to fine tune the production of long- and
short-chain fatty acid amides. By understanding this process more, it may be possible to
shine light on the undetermined biosynthetic pathways behind many fatty acid amides in
our bodies. It is apparent that AANATs carry the tools necessary to perform such a role.
Falcón et al. hypothesized that vertebrate AANAT (VTAANAT) and non-vertebrate
(NVTAANAT) diverged from each other 500 million years ago with the onset of AANAT
neofunctionalization.65 Through understanding this process, we may be able to address
the slew of diseases associated with the metabolism of these compounds such as
Alzheimer’s disease,66 Huntington’s disease,67 and Parkinson’s disease.68
While much work has been done to characterize insect AANATs, their
heterogeneity means that each individual form of the enzyme holds with it a treasure trove
of information pertaining to iAANAT evolution and fatty-acid amide metabolism. It is my
hope that this text will enrich this field and facilitate proposition of iAANATs as potential
insecticide targets.
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S1:

TcAANAT1b Michaelis Menten Plots

Figure S1: 5 mM histamine and varied acetyl-CoA
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Figure S2: 5 mM histamine and varied butyryl-CoA

Figure S3: 5 mM histamine and varied decanoyl-CoA
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Figure S4: 200 μM acetyl-CoA and varied dopamine

Figure S5: 200 μM acetyl-CoA and varied 2-2,-difluoro-2-phenethylamine
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Figure S6: 200 μM acetyl-CoA and varied histamine

Figure S7: 200 μM acetyl-CoA and varied norepinephrine
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Figure S8: 200 μM acetyl-CoA and varied octopamine

Figure S9: 200 μM acetyl-CoA and varied serotonin
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S2:

TcAANAT0 (wild-type) Michaelis Menten Plots

Figure S10: 5 mM tryptamine and varied acetyl-CoA

Figure S11: 5 mM tryptamine and varied propionyl-CoA

198

Figure S12: 5 mM tryptamine and varied butyryl-CoA

Figure S13: 5 mM tryptamine and varied crotonyl-CoA
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Figure S14: 5 mM tryptamine and varied DL-β-hydroxybutyryl-CoA

Figure S15: 5 mM tryptamine and varied decanoyl-CoA
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Figure S16: 5 mM tryptamine and varied succinyl-CoA

Figure S17: 5 mM tryptamine and varied benzoyl-CoA
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Figure S18: 250 μM acetyl-CoA and varied dopamine

Figure S19: 250 μM acetyl-CoA and varied serotonin
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Figure S20: 250 μM acetyl-CoA and varied tryptamine

Figure S21: 250 μM acetyl-CoA and varied norepinephrine
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Figure S22: 250 μM acetyl-CoA and varied 2-phenethylamine

Figure S23: 250 μM acetyl-CoA and varied agmatine
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Figure S24: 250 μM acetyl-CoA and varied histamine

Figure S25: 250 μM acetyl-CoA and varied ethanolamine
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Figure S26: 250 μM acetyl-CoA and varied tyramine

Figure S27: 250 μM acetyl-CoA and varied octopamine
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S3:

TcAANAT0 (Mutants) Michaelis Menten Plots

Figure S28: E25A – 5 mM tryptamine and varied acetyl-CoA

Figure S29: E25A – 250 μM acetyl-CoA and varied tryptamine
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Figure S30: E25D – 5 mM tryptamine and varied acetyl-CoA

Figure S31: E25D – 250 μM acetyl-CoA and varied tryptamine

208

Figure S32: R134A – 5 mM tryptamine and varied acetyl-CoA

Figure S33: R134A – 250 μM acetyl-CoA and varied tryptamine
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S4:

Bm-iAANAT3 Michaelis Menten Plots

Figure S34: 8 mM tryptamine and varied acetyl-CoA

Figure S35: 8 mM tryptamine and varied butyryl-CoA
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Figure S36: 8 mM tryptamine and varied hexanoyl-CoA

Figure S37: 8 mM tryptamine and varied decanoyl-CoA
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Figure S38: 500 μM acetyl-CoA and varied dopamine

Figure S39: 500 μM acetyl-CoA and varied histamine
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Figure S40: 500 μM acetyl-CoA and varied norepinephrine

Figure S41: 500 μM acetyl-CoA and varied octopamine
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Figure S42: 500 μM acetyl-CoA and varied serotonin

Figure S43: 500 μM acetyl-CoA and varied tryptamine
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Figure S44: 500 μM acetyl-CoA and varied tyramine
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S5:

SDS Gels

70

70
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35
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15

15

Figure S45: SDS-PAGE gel of purified TcAANAT1b (left), TcAANAT0 (center),
and Bm-iAANAT3 (right).
Lane 1 – PageRuler™ prestained protein
Lane 2 – Purified protein

ladder (Thermo
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